Alaris® System
Data Set Report
APPROVED
WVHN 8-16-2011
WVHN
__________________________________ a(n) __________________________________corporation
(Name)
(State Incorporated)
__________________________________
(Address)
_____________________________________
(City, State, Zip)
WVHN acknowledges that WVHN's unique data sets (Customized Data Set) have been developed by WVHN in accordance with WVHN's best practices protocols,
for use with Guardrails® Safety Software. WVHN acknowledges that it is the owner of the Customized Data Set and, as such, is solely responsible for the
development, verification and usage of the Customized Data Set in accordance with WVHN's best practices protocols.
At WVHN's request, ALARIS personnel may assist WVHN with the upload of WVHN's Customized Data Sets pursuant to the ALARIS® SMARTServiceSM
Implementation Program or other service agreements.
Further, WVHN acknowledges that the person signing this agreement on behalf of WVHN is authorized to execute this agreement on behalf of WVHN.
Signature
WVHN - 8/12/2011 08:17
Name
Title
Page 1 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Date
1. Current Data Set Status
Data Set Name
WVHN 8-16-2011
Hospital Name
WVHN
Data Set ID
015d79e05-A
Data Set Status
Approved
Last Changed On
8/12/2011 08:17
Filename
C:\Documents and Settings\timothyn\My Documents\Guardrails Editor\015d793c3-R.gre
WVHN - 8/12/2011 08:17
Page 2 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
2. Drug Library by Profile
2.1 Critical Care
2.1.1 Continuous/Bolus - Non-Anesthesia Drugs
Drug Name
Therapy
Concentrations
abciximab
.weight under 80Kg
--- mg / --- mL
abciximab
Weight >= to 80kg
7.2 mg / 250 mL (0.029 mg / mL)
Adenosine (CATH LAB)
--- mg / --- mL
alteplase
MI 67KG or less
--- mg / --- mL
alteplase
MI greater than 67KG
100 mg / 100 mL (1 mg / mL)
alteplase
Pulmonary Embolism
100 mg / 100 mL (1 mg / mL)
alteplase
Stroke 100kg or less
--- mg / --- mL
alteplase
Stroke above 100kg
90 mg / 90 mL (1 mg / mL)
WVHN - 8/12/2011 08:17
Module
P
X
X
X
X
X
X
X
X
S
Continuous/Bolus - Non-Anesthesia Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
0.12
0.126 0.127 0.125
---mcg/kg/min
Conc.
Limits
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
Clinical Ads.
Name
--
-n/a
Continuous
mcg/min
9.5
--
10.5
10
--
--
--
--
--
--
--
--
--
NO
Continuous
mcg/kg/min
50
200
--
140
--
--
--
--
--
--
--
--
Stress Test
YES Continuous
mg/kg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
n/a Continuous
mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
n/a Continuous
mg/h
0.5
1.5
1.7
1.5
14
15
16
15
14
15
--
15
--
35
100
101
100
14
15
16
15
14
16
--
15
--
49
51
--
50
--
--
--
--
--
--
--
--
--
YES Continuous
mg/kg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
n/a Continuous
mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
0.78
0.82
--
0.81
0.08
0.09
--
0.09
0.04
0.09
--
0.045
--
80
82
--
81
8.9
9.1
--
9
4
9.1
--
4.5
--
--
--
--
--
--
--
--
Page 3 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
alteplase
Vascular Occlusions
25 mg / 125 mL (0.2 mg / mL)
--- mg / --- mL
AminocaproicINFUSION
Module
P
X
X
5 gram / 250 mL (0.02 gram / mL)
AMINOphyllineINFUSIO
X
1,000 mg / 1,000 mL (1 mg / mL)
AMIODArone
X
900 mg / 500 mL (1.8 mg / mL)
argatroban
.Standard Dosing
125 mg / 125 mL (1 mg / mL)
argatroban
Hepatic Dose
125 mg / 125 mL (1 mg / mL)
atracurium
X
50 mg / 250 mL (0.2 mg / mL)
100 mg / 500 mL (0.2 mg / mL)
125 mg / 250 mL (0.5 mg / mL)
bivalirudin
.Standard Dosing
250 mg / 50 mL (5 mg / mL)
X
X
X
bivalirudin
Renal Dose
250 mg / 50 mL (5 mg / mL)
X
X
X
S
X
X
200 mg / 200 mL (1 mg / mL)
--- mg / --- mL
X
X
--
Continuous
gram/h
1
2
5
1
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/h
10
40
60
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/min
0.5
1
1.5
--
--
--
--
--
--
--
--
--
Filter 0.22
Micron
n/a
Continuous
mcg/kg/min
0.45
10
10.1
1.5
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mcg/kg/min
0.1
5
10.1
0.5
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mcg/kg/min
1.8
30
39
--
--
--
--
--
--
--
--
--
Neuromuscular
BA
n/a
Continuous
mg/kg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Continuous
mg/kg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Continuous
mg/h
0.095
1.8
--
1.75
0.3
0.76
--
0.75
0.3
0.76
--
0.75
--
0.24
1.1
--
1
0.3
0.76
--
0.75
0.3
0.76
--
0.75
--
0.1
4
8
--
--
--
--
--
--
--
--
--
--
0.5
6
10
--
0.05
0.15
0.2
0.1
0.05
0.15
0.2
0.1
Neuromuscular
BA
--
--
--
--
--
----
--
--
n/a
25 mg / 100 mL (0.25 mg / mL)
50 mg / 200 mL (0.25 mg / mL)
cisATRAcurium
Clinical Ads.
Name
n/a
n/a
X
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
---
bumetanide continuos
WVHN - 8/12/2011 08:17
Continuous/Bolus - Non-Anesthesia Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
0.5
2
5
----mg/h
Conc.
Limits
---
---
YES Continuous
mcg/kg/min
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Page 4 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Module
P
S
Clevidipine
n/a
25 mg / 50 mL (0.5 mg / mL)
dexmedeTOMidine
X
200 mcg / 50 mL (4 mcg / mL)
X
DOBUTamine
.Standard Dosing
500 mg / 250 mL (2 mg / mL)
--- mg / --- mL
DOBUTamine
Stress test
250 mg / 250 mL (1 mg / mL)
DOPamine
X
X
X
0.05
1
1.5
0.2
0.5
2
2.1
1
0.03
0.04
0.067
--
0.5
15
25
5
5
20
25.1
--
4
5
12.6
5
--
--
2.5
15
--
--
--
--
--
--
--
--
--
--
--
Continuous
mcg/kg/min
2.5
40
--
--
--
--
--
--
--
--
--
--
Stress Test
YES Continuous
mcg/kg/min
1
40
50
--
--
--
--
--
--
--
--
--
Central Line
Only
X
X
YES Continuous
mcg/kg/h
23
25.2
--
24
--
--
--
--
--
--
--
--
--
4 mg / 250 mL (0.016 mg / mL)
--- mg / --- mL
eptifibatide
.Standard Dosing
75 mg / 100 mL (0.75 mg / mL)
eptifibatide
.Weight121kg & above
75 mg / 100 mL (0.75 mg / mL)
X
X
X
X
X
YES Continuous
mcg/kg/h
23
25.2
--
24
--
--
--
--
--
--
--
--
--
X
X
YES Continuous
mcg/kg/min
0.01
0.5
--
--
--
--
--
--
--
--
--
--
Central Line
Only
n/a
Continuous
mcg/kg/min
0.5
2.2
--
2
--
--
--
--
--
--
--
--
CrCl > 50
mL/min
X
n/a
Continuous
mg/h
13
15.1
--
15
--
--
--
--
--
--
--
--
CrCl > 50
mL/min
X
0.033 12 Hour Tubing
--n/a
X
Initial
Value
--
Bolus Dose Administration
Rate
Clinical Ads.
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----12 Hour Tubing
Continuous
mcg/kg/h
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
n/a Continuous
mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
YES Continuous
mcg/kg/min
n/a
400 mg / 250 mL (1.6 mg / mL)
--- mg / --- mL
drotrecogin
.weight under 80Kg
10 mg / 50 mL (0.2 mg / mL)
20 mg / 100 mL (0.2 mg / mL)
--- mg / --- mL
drotrecogin
Weight >= to 80kg
20 mg / 100 mL (0.2 mg / mL)
--- mg / --- mL
EPINEPHrine
WVHN - 8/12/2011 08:17
Continuous/Bolus - Non-Anesthesia Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
1
32
-----mg/h
--
diltiazem
125 mg / 125 mL (1 mg / mL)
Conc.
Limits
--
---
----
---
---
--
--
Page 5 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
eptifibatide
Renal Dose
75 mg / 100 mL (0.75 mg / mL)
eptifibatide
Renal Dose wt >121kg
75 mg / 100 mL (0.75 mg / mL)
esmolol
2,500 mg / 250 mL (10 mg / mL)
Module
P
S
n/a
X
X
X
X
X
2,000 mcg / 100 mL (20 mcg / mL)
X
--- unit / --- mL
Heparin EP LAB
X
500 unit / 500 mL (1 unit / mL)
X
insulin
Non-anesthesia
150 unit / 150 mL (1 unit / mL)
--- unit / --- mL
WVHN - 8/12/2011 08:17
6
7.6
--
7.5
--
--
--
--
--
--
--
--
CrCl < 50
mL/min
n/a
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
mcg/kg/min
25
300
--
100
100
500
--
--
100
500
--
--
--
0.01
0.1
0.4
--
--
--
--
--
--
--
--
--
--
10
100
--
--
25
100
--
50
12.5
50
--
50
--
0.5
6
--
--
25
100
--
50
12.5
50
--
50
--
1
80
160
--
--
--
--
--
--
--
--
--
--
YES Continuous
unit/h
200
2500
3500
--
--
--
--
--
--
--
--
--
2nd RN to verify
Continuous
unit/h
Bolus Dose
unit
Bolus Admin Rate
unit/min
YES Continuous
unit/h
10
999
--
30
10
999
--
--
0.5
16.5
--
16.5
NOTE
CONCENTRATI
ON
0.1
25
75
--
--
--
--
--
--
--
--
--
2nd RN to verify
--
---
--
--
FUROSemide
X
X
Continuous
mcg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
n/a Continuous
mcg/kg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
YES Continuous
mg/h
---
-n/a
X
X
CrCl < 50
mL/min
--
fentaNYL
1,000 mg / 100 mL (10 mg / mL)
--- mg / --- mL
heparin
Clinical Ads.
Name
Continuous
mg/h
n/a
X
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
n/a
n/a
10 mg / 250 mL (0.04 mg / mL)
20 mg / 250 mL (0.08 mg / mL)
fentaNYL
Continuous/Bolus - Non-Anesthesia Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.25
1.1
-1
---mcg/kg/min
--
fenoldopam
2,000 mcg / 100 mL (20 mcg / mL)
Conc.
Limits
--
---
Page 6 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Module
P
S
isoproterenol
n/a
1 mg / 250 mL (0.004 mg / mL)
IVIG 10%
X
5 gram / 50 mL (0.1 gram / mL)
10 gram / 100 mL (0.1 gram / mL)
20 gram / 200 mL (0.1 gram / mL)
ketamine
X
X
X
250 mg / 250 mL (1 mg / mL)
500 mg / 500 mL (1 mg / mL)
--- mg / --- mL
labetalol
X
X
X
300 mg / 150 mL (2 mg / mL)
500 mg / 250 mL (2 mg / mL)
lepirudin
.Standard Dosing
100 mg / 250 mL (0.4 mg / mL)
lepirudin
Weight above 110kg
100 mg / 250 mL (0.4 mg / mL)
lidocaine
X
X
2,000 mg / 500 mL (4 mg / mL)
LORazepam
X
40 mg / 120 mL (0.333 mg / mL)
--- mg / --- mL
X
X
X
X
X
WVHN - 8/12/2011 08:17
X
Clinical Ads.
Name
--
25
250
480
50
--
--
--
--
--
--
--
--
--
YES Continuous
mcg/kg/min
0.1
0.25
0.5
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/min
0.05
2.5
--
2
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/kg/h
0.01
0.2
0.3
--
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mg/h
16.4
16.6
16.7
16.5
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mg/min
0.5
4
5
--
--
--
--
--
--
--
--
--
--
YES Continuous
mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
YES Continuous
mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
n/a Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
0.25
10
25
--
1
10
10.1
--
1
5
5.1
5
Filter 0.22
Micron
0.25
20
--
--
0.5
5
--
--
1
2
--
2
--
0.25
0.75
0.8
--
25
50
55
50
1
5
--
--
--
----
----
---
--
--
--
---
---
milrinone
20 mg / 100 mL (0.2 mg / mL)
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
Continuous
mg/kg/h
n/a
X
Continuous/Bolus - Non-Anesthesia Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.5
10
-----mcg/min
--
midazolam
100 mg / 100 mL (1 mg / mL)
--- mg / --- mL
Conc.
Limits
--
Page 7 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Module
P
S
morphine
100 mg / 100 mL (1 mg / mL)
250 mg / 250 mL (1 mg / mL)
500 mg / 500 mL (1 mg / mL)
--- mg / --- mL
naloxone
X
X
X
X
0.8 mg / 250 mL (0.003 mg / mL)
4 mg / 1,000 mL (0.004 mg / mL)
--- mg / --- mL
nesiritide
X
X
X
1.5 mg / 250 mL (0.006 mg / mL)
X
-----
n/a
--
n/a
20 mg / 200 mL (0.1 mg / mL)
25 mg / 250 mL (0.1 mg / mL)
nitroGLYcerin
X
X
25 mg / 250 mL (0.1 mg / mL)
50 mg / 250 mL (0.2 mg / mL)
nitroPRUSSide
X
X
50 mg / 250 mL (0.2 mg / mL)
100 mg / 250 mL (0.4 mg / mL)
NORepinephrine
X
X
4 mg / 250 mL (0.016 mg / mL)
--- mg / --- mL
octreotide
X
X
1,500 mcg / 500 mL (3 mcg / mL)
--- mcg / --- mL
X
X
X
80 mg / 100 mL (0.8 mg / mL)
X
Clinical Ads.
Name
--
--
--
--
--
--
--
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
mg/h
0.005
0.01
0.3
0.01
0.5
2.1
--
2
0.5
2
--
--
--
0.5
15
--
2.5
--
--
--
--
--
--
--
--
Central
preferred
--n/a
Continuous
mcg/min
1
200
--
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mcg/kg/min
0.01
10
--
--
--
--
--
--
--
--
--
--
Protect From
Light
YES Continuous
mcg/kg/min
0.01
2
--
--
--
--
--
--
--
--
--
--
Central Line
Only
25
75
--
50
25
175
--
--
12
25
--
12.5
--
0.5
40
300
--
--
--
--
--
--
--
--
--
--
7
9
--
8
--
--
--
--
--
--
--
--
--
---
---
---
---
oxytocin
30 unit / 500 mL (0.06 unit / mL)
pantoprazole
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
0.25
2
---
----
niCARdipine
WVHN - 8/12/2011 08:17
Continuous/Bolus - Non-Anesthesia Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
0.5
25
--0.5
10
-mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
YES Continuous
0.064
3.9
-----mg/h
Conc.
Limits
YES Continuous
mcg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
n/a Continuous
milliunit/min
-n/a
Continuous
mg/h
--
Page 8 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Module
P
S
PHENYLephrine
40 mg / 250 mL (0.16 mg / mL)
--- mg / --- mL
procainamide
X
X
2,000 mg / 500 mL (4 mg / mL)
propofol
X
500 mg / 50 mL (10 mg / mL)
1,000 mg / 100 mL (10 mg / mL)
vasopressin
GI Varicies
100 unit / 250 mL (0.4 unit / mL)
vasopressin
Shock
100 unit / 250 mL (0.4 unit / mL)
vecuronium
X
X
100 mg / 250 mL (0.4 mg / mL)
X
X
X
Central Line
Only
Continuous
mg/min
1
4
5
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mcg/kg/min
5
70
80
--
--
--
--
--
--
--
--
--
12 Hour Tubing
n/a
Continuous
unit/min
0.2
1
--
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
unit/min
0.01
0.04
0.15
--
--
--
--
--
--
--
--
--
Central Line
Only
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
YES Continuous
mg/kg/h
0.01
2.5
--
--
5
120
--
--
5
120
--
--
Neuromuscular
BA
0.5
1.5
--
1
--
--
--
--
--
--
--
--
--
--
---
--
--
--
--
2.1.2 Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Critical Care
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
abciximab
X
-mcg/mL
-0.01
0.03
.weight under 80Kg
WeightBased
alteplase
X
-mg/mL
0.98
0.99
1.01
MI 67KG or less
WeightBased
alteplase
X
-mg/mL
0.98
0.99
1.01
Stroke 100kg or less
WeightBased
alteplase
X
-mg/mL
0.1
-0.3
Vascular Occlusions
NonWeightBased
WVHN - 8/12/2011 08:17
Clinical Ads.
Name
n/a
n/a
X
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
---
Zidovudine infusion
--- mg / --- mL
Continuous/Bolus - Non-Anesthesia Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
0.02
3
-----mcg/kg/min
Conc.
Limits
Page 9 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Critical Care
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
cisATRAcurium
X
-mcg/mL
998
1000
1001
WeightBased
DOBUTamine
.Standard Dosing
WeightBased
DOPamine
X
--
mcg/mL
--
1
4
X
--
mcg/mL
--
0.8
3.2
X
--
mcg/mL
--
199
201
X
--
mcg/mL
--
199
201
X
--
mcg/mL
--
0.016
0.1
WeightBased
FUROSemide
X
--
mg/mL
1
5
11
NonWeightBased
heparin
X
--
unit/mL
50
--
100
X
--
unit/mL
--
0.2
1.5
X
--
mcg/mL
--
500
2000
WeightBased
LORazepam
X
--
mg/mL
--
0.4
0.6
NonWeightBased
midazolam
X
--
mg/mL
--
0.5
1
NonWeightBased
morphine
X
--
mg/mL
--
1
1.5
NonWeightBased
naloxone
X
--
mg/mL
--
0.001
0.006
NonWeightBased
NORepinephrine
X
--
mcg/mL
16
--
64
WeightBased
drotrecogin
.weight under 80Kg
WeightBased
drotrecogin
Weight >= to 80kg
WeightBased
EPINEPHrine
NonWeightBased
insulin
Non-anesthesia
NonWeightBased
ketamine
WeightBased
WVHN - 8/12/2011 08:17
Page 10 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Critical Care
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
octreotide
X
-mcg/mL
-1
6
NonWeightBased
PHENYLephrine
X
--
mcg/mL
--
35
320
WeightBased
Zidovudine infusion
X
--
mg/mL
--
1
4
WeightBased
2.1.3 Continuous/Bolus - Anesthesia Only Drugs
Drug Name
Therapy
Concentrations
Module
P
S
atracurium
n/a
10 mg / 1 mL (10 mg / mL)
cisATRAcurium
--
2 mg / 1 mL (2 mg / mL)
--
X
X
--
fentaNYL
50 mcg / 1 mL (50 mcg / mL)
insulin
Anesthesia only
150 unit / 150 mL (1 unit / mL)
Ketamine ANES
250 mg / 250 mL (1 mg / mL)
500 mg / 500 mL (1 mg / mL)
--- mg / --- mL
WVHN - 8/12/2011 08:17
--
X
Continuous/Bolus - Anesthesia Only Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
1.8
30
39
----mcg/kg/min
X
YES Continuous
mcg/kg/min
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
YES Continuous
mg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
n/a Continuous
mcg/kg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
n/a Continuous
unit/h
0.5
6
10
--
0.05
0.15
0.2
0.1
0.05
0.15
0.2
0.1
Neuromuscular
BA
100
500
--
--
0.5
2.5
2.7
1
0.001
0.04
--
0.017
--
0.5
6
--
--
25
100
--
50
12.5
50
--
50
--
0.1
25
75
--
--
--
--
--
--
--
--
--
2nd RN to verify
0.5
3
--
--
--
--
--
--
--
--
--
--
--
-YES Continuous
mg/min
X
X
X
Initial
Value
--
Bolus Dose Administration
Clinical Ads.
Rate
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----Neuromuscular
BA
X
dantrolene ANESTHESI
--- mg / --- mL
Conc.
Limits
----
Page 11 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Module
P
S
midazolam
1 mg / 1 mL (1 mg / mL)
n/a
--
X
Propofol ANESTHESIA
10 mg / 1 mL (10 mg / mL)
500 mg / 50 mL (10 mg / mL)
1,000 mg / 100 mL (10 mg / mL)
n/a
-X
X
X
---
protamine sulfate
10 mg / 1 mL (10 mg / mL)
n/a
--
X
remifentanil
50 mcg / 1 mL (50 mcg / mL)
n/a
--
X
rocuronium
10 mg / 1 mL (10 mg / mL)
n/a
--
X
succinylcholine
20 mg / 1 mL (20 mg / mL)
n/a
--
X
SUFentanil
50 mcg / 1 mL (50 mcg / mL)
WVHN - 8/12/2011 08:17
Conc.
Limits
n/a
--
X
Continuous/Bolus - Anesthesia Only Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.5
6
--10
300
-mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
5
300
--100
3000
-mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
0.1
5
--5
50
-mg/min
Bolus Dose
mg
Bolus Admin Rate
mg/min
Continuous
0.125
1.5
--0.25
1
-mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
1
20
--10
1200
-mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
1
4.3
--0.1
1.2
-mg/min
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Continuous
0.1
2
--0.5
5
-mcg/kg/h
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Page 12 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
10
25
---
Clinical Ads.
Name
--
--
100
1500
--
--
--
--
1
5
--
--
--
--
0.25
1.5
--
--
--
--
10
1200
--
--
--
--
0.3
2.8
--
2.4
--
--
0.5
2.5
--
--
--
Conc.
Limits
Module
Drug Name
Therapy
Concentrations
P
S
vecuronium
n/a
1 mg / 1 mL (1 mg / mL)
--
X
Continuous/Bolus - Anesthesia Only Drugs - Critical Care
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.01
2.5
--5
120
-mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Initial
Value
--
Bolus Dose Administration
Clinical Ads.
Rate
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
5
120
--Neuromuscular
BA
2.1.4 Continuous/Bolus - Anesthesia Only Drugs - Concentration Limits
Continuous/Bolus - Anesthesia Only Drugs - Concentration Limits - Critical Care
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
dantrolene ANESTHESI
X
-mg/mL
-0.3
0.35
NonWeightBased
Ketamine ANES
X
--
mg/mL
--
0.5
2
NonWeightBased
2.1.5 Intermittent Drugs
Intermittent Drugs - Critical Care
Available
As
Drug Name
Therapy
Acetaminophen
pt weight < 50kg
Acetaminophen
pt weight >= 50kg
acetaZOLAMIDE
acetylcysteine
First Dose
acetylcysteine
Second Dose
acetylcysteine
Third Dose
acyclovir
albumin 25%
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Concentrations
--- mg / --- mL
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
P
S
Hard
Min
X
--
00:10
--
00:30
00:15 mg/mL
X
--
00:10
--
00:30
00:15
X
X
mg/kg
10
17
X
X
mg
650
--
X
X
mg
100
1000
--
--- mg / --- mL
X
--
--
00:15
01:00
X
X
mg/kg
140
160
--
--- mg / --- mL
X
--
--
00:30
X
X
mg/kg
40
60
--
--- mg / --- mL
X
--
--
X
X
mg/kg
90
110
--
--- mg / --- mL
X
--
X
X
mg
100
2000
--
--- mg / --- mL
X
X
X
gram
12.5
25
--
12.5 gram / 50 mL (0.25 gram / mL)
25 gram / 100 mL (0.25 gram / mL)
X
X
WVHN - 8/12/2011 08:17
--
Module
1000 1,000 mg / 100 mL (10 mg / mL)
Page 13 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Clinical Ads.
Name
--
9.9
10.1
--
n/a
n/a
n/a
--
00:30 mg/mL
--
10
100
--
02:00
01:00 mg/mL
1
--
75
--
03:30
05:00
04:00 mg/mL
1
--
75
--
--
13:20
18:00
16:00 mg/mL
1
--
75
--
--
--
00:45
02:00
01:00 mg/mL
--
0.5
7
--
---
---
00:15
00:20
01:00
01:00
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
--
n/a
n/a
n/a
Intermittent Drugs - Critical Care
Available
As
Drug Name
Therapy
albumin 5%
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
ampho B
(LIPOSOMAL)
amphotericin B
.Standard Dosing
amphotericin B
Blasto load < 100 KG
amphotericin B
Blasto load >= 100KG
amphotericin B
Blasto Maintenance
ampicillin
P
S
12.5 gram / 250 mL (0.05 gram / mL)
X
--
--
00:15
01:00
--
5 gram / 250 mL (0.02 gram / mL)
X
--
--
00:45
01:30
01:00
--- gram / --- mL
X
--
--
00:45
01:30
--
150 mg / 100 mL (1.5 mg / mL)
--- mg / --- mL
X
X
---
---
00:08
00:08
5.5
--
--- mg / --- mL
X
--
--
1
100
--
--- mg / --- mL
X
--
mg/kg
0.45
0.55
0.6 --- mg / --- mL
X
X
mg
45
50
55
50 mg / 500 mL (0.1 mg / mL)
X
mg/kg
0.6
0.9
1
--
X
X
gram
12.5
13
--
X
X
gram
4
5
--
X
X
mg
149
151
X
X
mg/kg
2.8
X
X
mg
X
X
X
X
X
X
gram
0.2
3
ampicillin/sulbact
X
azithromycin
X
gram
0.1
3
4.5
X
X
mg
250
500
--
X
X
gram
0.25
2
--
aztreonam
Bumetanide in HSS
calcium chloride
calcium gluconate
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
Aminocaproic LOAD
AMIODArone Loading
Module
X
X
mg
2
X
X
mg
500
X
X
mg
500
X
X
gram
0.25
ceFAZolin
WVHN - 8/12/2011 08:17
Concentrations
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.02
00:15
01:00
n/a
gram/m
01:00
L
00:10
n/a
-mg/mL
n/a
--
n/a
1
n/a
3
--
01:00
04:00
02:00 mg/mL
--
0.2
2
--
00:59
--
06:00
--
0.05
0.25
--
--
02:30
03:30
03:00 mg/mL 0.009
0.09
0.25
X
--
--
02:30
03:30
03:00
n/a
n/a
n/a
--- mg / --- mL
X
--
22:00
23:00
25:00
24:00 mg/mL
--
0.009
0.25
0.5 gram / 50 mL (0.01 gram / mL)
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
----
----
00:25
00:25
00:25
01:00
01:00
01:00
00:30
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:25
01:00
00:30
--
0.1
1.5 gram / 50 mL (0.03 gram / mL)
3 gram / 100 mL (0.03 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:25
01:00
00:30
--
0.45
500 mg / 250 mL (2 mg / mL)
--- mg / --- mL
1 gram / 100 mL (0.01 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
X
-----
00:50
00:50
---
--00:25
00:25
03:00
03:00
01:00
01:00
01:00
01:00
00:30
00:30
n/a
0.5
n/a
n/a
n/a
2.5
n/a
n/a
--- gram / --- mL
X
--
--
00:25
01:00
00:30
--
0.2
X
X
X
X
X
X
X
X
X
----------
00:25
00:25
00:25
--00:10
00:10
---
---00:08
00:08
00:15
00:15
00:25
00:25
00:45
00:45
00:45
02:00
02:00
06:00
06:00
01:00
01:00
00:30
00:30
00:30
01:00
01:00
01:00
01:00
00:30
00:30
n/a
n/a
0.012
n/a
-n/a
10
n/a
n/a
n/a
n/a
0.08
n/a
100
n/a
200
n/a
n/a
X
--
--
00:25
01:00
00:30
0.01
0.04
4 mg / 150 mL (0.027 mg / mL)
8 mg / 150 mL (0.053 mg / mL)
--- mg / --- mL
1,000 mg / 50 mL (20 mg / mL)
1000 1500
--- mg / --- mL
1,000 mg / 50 mL (20 mg / mL)
2000
---- mg / --- mL
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
2
---- gram / --- mL
10
--
Page 14 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
n/a
Clinical Ads.
Name
mg/mL
n/a
n/a
n/a
n/a
n/a
n/a
n/a
gram/m
0.005
L
n/a
n/a
n/a
n/a
gram/m
0.015
L
n/a
n/a
mg/mL
-n/a
n/a
n/a
n/a
gram/m
0.001
L
n/a
n/a
n/a
n/a
mg/mL
-n/a
n/a
mg/mL
10
n/a
n/a
mg/mL
-n/a
n/a
n/a
n/a
gram/m
-L
---
Protect From
Light
Protect From
Light
Protect From
Light
Protect From
Light
--
--
--
--
-Central Line
Only
--
--
Intermittent Drugs - Critical Care
Available
As
Drug Name
Therapy
cefePIME
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
gram
0.25
2
--
cefoTAXime
X
X
gram
0.25
2
--
cefOXitin
X
X
gram
0.5
2
--
cefTAZidime
X
X
gram
0.5
2
--
cefTRIAXone
X
chlorothiazide
CIPROfloxacin
X
gram
0.125
2
--
DAPTOmycin
desmopressin
digoxin immune fab
doxyCYCLINE
Concentration Limits
Initial Conc. Hard
Soft
Soft
Value Units
Min
Min
Max
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
Concentrations
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
P
X
X
S
---
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
--- mg / --- mL
X
--
--
00:15
02:00
00:30 mg/mL
--
1
30
200 mg / 100 mL (2 mg / mL)
400 mg / 200 mL (2 mg / mL)
300 mg / 50 mL (6 mg / mL)
600 mg / 50 mL (12 mg / mL)
900 mg / 50 mL (18 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
-------
-------
00:50
00:50
00:10
00:20
00:20
00:10
02:00
02:00
01:00
01:00
01:00
01:00
01:00
n/a
01:00
n/a
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
n/a
n/a
n/a
n/a
n/a
--
n/a
n/a
n/a
n/a
n/a
3
n/a
n/a
n/a
n/a
n/a
18
Clinical Ads.
Name
--
--
--
--
--
X
mg
250
2000
--
X
X
mg
200
400
--
X
X
mg
50
900
--
X
X
mg/kg
1
2.5
--
--- mg / --- mL
X
--
--
00:50
03:00
01:00 mg/mL
--
0.2
0.35
--
X
X
mg
250
500
--
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
---
---
00:25
00:25
01:00
01:00
00:30
n/a
00:30 mg/mL
n/a
2
n/a
--
n/a
15
--
X
X
mcg/kg
0.25
0.35
--
--- mcg / --- mL
X
--
--
00:15
01:00
00:30 mcg/mL
--
0.01
4
--
X
X
mg
10
800
--
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
--
0.1
1
Filter 0.22
Micron
X
X
mg
25
200
--
100 mg / 250 mL (0.4 mg / mL)
--- mg / --- mL
1 gram / 50 mL (0.02 gram / mL)
X
X
X
----
----
00:45
00:45
00:25
04:00
04:00
02:00
n/a
-n/a
n/a
0.1
n/a
n/a
1
n/a
X
X
gram
0.45
1.25
--
--- gram / --- mL
X
--
--
00:25
02:00
--
0.01
0.02
X
X
mg
100
1000
--
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
---
---
00:30
00:30
02:00
02:00
01:00
n/a
01:00 mg/mL
00:30
n/a
gram/m
00:30
L
01:30
n/a
01:30 mg/mL
n/a
--
n/a
1
n/a
5
ertapenem
erythromycin
Duration Limits
Soft
Soft
Min
Max
00:25 01:00
00:25 01:00
Hard
Min
---
X
CLINDAmycin
dantrolene
Module
WVHN - 8/12/2011 08:17
Page 15 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
---
--
----
Intermittent Drugs - Critical Care
Available
As
Drug Name
Therapy
Estrogen, conjugated
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
mg
5
25
--
X
X
mg
62.5
500
--
X
X
mg
50
800
--
X
X
mg/kg
9
16
--
X
X
mg
25
2000
X
X
mg
100
500
X
X
mg/kg
0.625
8
X
X
mg
40
800
X
X
mg/kg
X
X
X
ferric gluconate Na
fluCONazole
fomepizole
fosphenytoin
furosemide in HSS
GANcyclovir
gentamicin
ibutilide
pt weight < 60kg
ibutilide
pt weight >= 60kg
imipenem/cilastatin
inFLIXimab
iron DEXTRAN
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
P
S
Hard
Min
25 mg / 50 mL (0.5 mg / mL)
X
--
--
00:15
00:45
00:30
125 mg / 100 mL (1.25 mg / mL)
250 mg / 250 mL (1 mg / mL)
--- mg / --- mL
100 mg / 50 mL (2 mg / mL)
200 mg / 100 mL (2 mg / mL)
400 mg / 200 mL (2 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
X
--------
--------
00:10
00:20
01:00
00:30
00:30
00:30
00:30
00:30
02:30
03:00
04:00
04:00
04:00
04:00
--- mg / --- mL
X
--
--
00:25
X
X
X
X
X
X
X
X
X
----------
--00:25
00:25
00:25
--00:25
00:45
Concentrations
100 mg / 50 mL (2 mg / mL)
--- mg / --- mL
250 mg / 150 mL (1.667 mg / mL)
1000 500 mg / 150 mL (3.333 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
---- mg / --- mL
80 mg / 100 mL (0.8 mg / mL)
---- mg / --- mL
--
n/a
n/a
n/a
n/a
00:15
n/a
02:00
n/a
-mg/mL
01:00
n/a
01:00
n/a
02:00
n/a
-mg/mL
n/a
n/a
-n/a
n/a
n/a
--
n/a
n/a
1
n/a
n/a
n/a
1
n/a
n/a
5
n/a
n/a
n/a
2
01:00
00:30 mg/mL
--
1
20
00:10
00:10
---00:50
00:50
---
00:30
00:30
00:45
00:45
00:45
02:00
02:00
01:20
01:20
00:20
00:20
00:30
00:30
00:30
01:00
01:00
01:00
01:00
n/a
-n/a
n/a
0.5
n/a
-n/a
0.5
n/a
1.5
n/a
n/a
-n/a
1
n/a
--
n/a
25
n/a
n/a
7
n/a
10
n/a
10
--
0.001
0.02
--
n/a
n/a
n/a
--
n/a
n/a
n/a
--
n/a
n/a
n/a
2
n/a
n/a
n/a
5
--
--
0.4
4
Hypersensitivity
--
n/a
mg/mL
n/a
n/a
mg/mL
n/a
mg/mL
n/a
mg/mL
0.009 0.011
--
--- mg / --- mL
X
--
00:04
00:05
00:30
00:10 mg/mL
mg
0.85
1.25
--
1 mg / 50 mL (0.02 mg / mL)
X
--
00:04
00:05
00:30
00:10
X
mg
100
1000
--
250 mg / 100 mL (2.5 mg / mL)
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
X
X
X
X
-----
-----
00:25
00:25
00:50
00:25
01:00
01:00
02:00
02:00
00:30
n/a
00:30
n/a
01:00
n/a
-mg/mL
X
X
mg/kg
2
10
--
--- mg / --- mL
X
--
--
01:55
25:00
X
X
mg
100
2000
--
--- mg / --- mL
X
--
01:00
01:30
04:00
X
X
X
X
X
X
X
X
X
X
------X
----
----00:10
00:10
00:10
----
00:06
00:15
01:00
00:15
---00:50
00:50
01:15
01:00
01:00
02:00
05:00
00:30
00:30
00:30
02:00
02:00
02:00
iron sucrose
X
X
mg
25
X
X
mg
250
X
X
mg
250
levETIRAcetam
levoFLOXacin
WVHN - 8/12/2011 08:17
100 mg / 100 mL (1 mg / mL)
200 mg / 100 mL (2 mg / mL)
500
-300 mg / 250 mL (1.2 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1500 3000 1,000 mg / 100 mL (10 mg / mL)
--- mg / --- mL
250 mg / 50 mL (5 mg / mL)
750
-- 500 mg / 100 mL (5 mg / mL)
750 mg / 150 mL (5 mg / mL)
Page 16 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Clinical Ads.
Name
n/a
--
mg/mL
--
mg/mL
00:15
n/a
00:30
n/a
01:30
n/a
-mg/mL
00:15
n/a
00:15
n/a
00:15 mg/mL
01:00
n/a
01:00
n/a
01:30
n/a
--
2
4
n/a
n/a
n/a
-n/a
n/a
-n/a
n/a
n/a
n/a
n/a
n/a
0.2
n/a
n/a
2.5
n/a
n/a
n/a
n/a
n/a
n/a
2.1
n/a
n/a
15
n/a
n/a
n/a
---
--
------
Hypersensitivity
--
--
Intermittent Drugs - Critical Care
Available
As
Drug Name
Therapy
linezolid
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
mg
400
800
mannitol 20%
X
gram
0.5
7
methylpred spin bol
Methylpred spine inf
methylPREDNISolone
P
S
600 mg / 300 mL (2 mg / mL)
X
--
00:45
--
02:00
01:00
n/a
n/a
n/a
n/a
--
8
1 gram / 100 mL (0.01 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
4 gram / 100 mL (0.04 gram / mL)
X
X
X
----
----
00:25
00:25
00:50
02:00
04:00
08:00
01:00
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
--
--- gram / --- mL
X
--
--
00:30
12:00
--
n/a
n/a
n/a
gram/m
L
gram/m
L
n/a
n/a
mg/mL
--
0.01
0.12
--
0.2
0.25
--
n/a
n/a
--
n/a
n/a
2
n/a
n/a
4
--
moxifloxacin
X
gram
10
50
--
--- gram / --- mL
X
--
00:25
--
01:30
00:30
X
X
mg
250
4000
--
500 mg / 50 mL (10 mg / mL)
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:25
00:25
00:25
01:00
01:00
01:00
00:30
00:30
00:30
X
X
mg/kg
0.5
2
--
--- mg / --- mL
X
--
00:20
--
01:00
00:30 mg/mL
--
1
10
--
X
X
mg/kg
27
--
33
--- mg / --- mL
X
--
--
00:10
00:25
00:15 mg/mL
--
12
90
--
X
X
gram/kg
0.12
0.13
--
--- gram / --- mL
X
--
22:00
22:30
23:30
23:00
gram/m
L
--
0.012
0.045
gram/kg =
mg/kg/hour
X
X
mg
250
2000
--
--- mg / --- mL
X
--
00:15
--
01:00
00:30 mg/mL
--
2.5
40
--
X
X
mg
250
1000
--
250 mg / 50 mL (5 mg / mL)
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:25
00:25
00:50
02:00
02:00
02:00
00:30
n/a
00:30
n/a
01:00 mg/mL
n/a
n/a
--
n/a
n/a
2
n/a
n/a
5
--
X
X
mg
49
151
X
--
--
00:45
01:30
01:00 mg/mL
--
0.49
1.51
--
X
X
mg
300
500
400 mg / 250 mL (1.6 mg / mL)
X
--
--
00:30
02:00
01:00
n/a
n/a
n/a
--
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:30
01:30
00:30
01:00
n/a
n/a
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:25
01:30
n/a
n/a
gram/m
00:30
L
--
0.01
0.04
300 --- mg / --- mL
--
nafcillin
X
ondansetron
pamidronate
penG 2.5 Mill Units
penG 5 million units
Penicillin G
PENTobarbital
Concentrations
X
metroNIDAZOLE
micafungin
Clinical Ads.
Name
--
meropenem
Methylene BLUE
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
magnesium sulfate
X
Module
X
gram
0.2
2
--
n/a
--
X
X
mg
2
32
--
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
0.04
0.64
--
X
X
mg
29
90
--
90 mg / 250 mL (0.36 mg / mL)
--- mg / --- mL
X
X
---
---
02:00
02:00
06:00
06:00
04:00
n/a
04:00 mg/mL
n/a
--
n/a
0.001
n/a
0.4
Dedicated IV
Line
X
X
unit
2
3
--
2.5 unit / 100 mL (0.025 unit / mL)
X
--
--
00:25
01:00
00:30
n/a
n/a
n/a
n/a
1unit=1million
X
X
unit
4.5
5.5
--
5 unit / 250 mL (0.02 unit / mL)
X
--
--
00:25
02:00
00:30
n/a
n/a
n/a
n/a
1unit=1million
X
X
unit
1
5
--
--- unit / --- mL
X
--
--
00:25
01:00
00:30 unit/mL
0.02
--
0.05
1unit=1million
X
X
mg/kg
5
15
--
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
--
1
8
Filter 0.22
Micron
WVHN - 8/12/2011 08:17
Page 17 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Intermittent Drugs - Critical Care
Available
As
Drug Name
Therapy
phenytoin
Loading Dose
phenytoin
Maintenance Dose
Pip/Tazo Extended
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
potassium PHOSphate
Peripheral
P
S
X
mg/kg
5
25
--
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
1
10
X
X
mg/kg
0.5
2.5
--
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
1
10
X
X
gram
3
4
--
3.37 gram / 50 mL (0.067 gram / mL)
X
--
--
03:45
04:30
04:00
n/a
n/a
n/a
n/a
X
X
gram
0.75
4.5
--
X
X
mEq
5
60
--
2.25 gram / 50 mL (0.045 gram / mL)
3.37 gram / 50 mL (0.067 gram / mL)
4.5 gram / 100 mL (0.045 gram / mL)
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 50 mL (0.4 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
X
X
X
X
-------
---00:20
00:30
--
00:25
00:25
00:25
00:25
00:50
00:50
01:00
01:00
01:00
02:00
02:00
02:00
00:30
00:30
00:30
00:30
01:00
01:00
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
--- mEq / --- mL
X
--
00:50
01:00
04:00
--
0.1
--
0.4
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
---
00:40
00:30
00:50
01:00
03:00
06:00
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
--- mEq / --- mL
X
--
00:50
01:00
04:00
--
0.1
--
0.2
14 mmol / 250 mL (0.056 mmol / mL)
15 mmol / 100 mL (0.15 mmol / mL)
X
X
---
02:00
02:00
---
06:00
06:00
03:00
03:00
n/a
n/a
n/a
n/a
n/a
n/a
--- mmol / --- mL
X
--
03:00
--
09:00
04:00
--
0.01
0.24
14 mmol / 250 mL (0.056 mmol / mL)
X
--
02:00
--
06:00
03:00
n/a
n/a
n/a
--- mmol / --- mL
X
--
02:00
--
06:00
--
n/a
n/a
n/a
n/a
n/a
n/a
mEq/m
L
n/a
n/a
mEq/m
L
n/a
n/a
mmol/m
L
n/a
mmol/m
L
n/a
n/a
mg/mL
--
0.01
0.07
n/a
n/a
--
n/a
n/a
0.1
n/a
n/a
6
--
X
X
X
X
mEq
mmol
5
14
40
40
--
--
SMX/TMP
tigeCYCLINE
TOBRAmycin
valproate sodium
Vanco Langlade
Filter 0.22
Micron
Filter 0.22
Micron
---
--
--
--
X
mmol
10
30
--
X
X
mg
100
600
--
300 mg / 250 mL (1.2 mg / mL)
600 mg / 500 mL (1.2 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:50
00:50
00:55
03:00
03:00
03:00
01:00
01:00
--
X
X
mcg/kg
0.018 0.22
--
--- mcg / --- mL
X
--
00:30
00:55
01:10
01:00 mcg/mL
--
0.02
0.6
--
X
X
mg/kg
1.5
6
--
--- mg / --- mL
X
--
00:45
--
02:00
01:00 mg/mL
--
0.1
1.2
48 Hour Tubing
15 mmol / 250 mL (0.06 mmol / mL)
X
--
02:00
--
06:00
03:00
X
X
mmol
10
60
--
--- mmol / --- mL
X
--
02:00
--
06:00
--
X
X
gram
2
3.1
--
3.1 gram / 100 mL (0.031 gram / mL)
X
--
--
00:25
01:00
00:30
X
X
mg
25
100
--
X
X
mg
40
600
--
50 mg / 50 mL (1 mg / mL)
100 mg / 100 mL (1 mg / mL)
80 mg / 100 mL (0.8 mg / mL)
--- mg / --- mL
X
X
X
X
-----
--00:25
00:25
00:25
00:25
---
01:00
01:00
01:00
01:00
X
X
mg
250
2000
--
--- mg / --- mL
X
--
--
00:50
X
X
mg
210
2000
--
500 mg / 100 mL (5 mg / mL)
X
--
--
00:30
sodium phosphate
ticarcillin/clav
Concentrations
X
rifampin
Sincalide
Clinical Ads.
Name
X
potassium chloride
Central
potassium PHOSphate
Central
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
piperacillin/tazo
potassium chloride
Peripheral
Module
WVHN - 8/12/2011 08:17
Page 18 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
n/a
mmol/m
L
n/a
n/a
n/a
--
0.03
0.3
n/a
n/a
n/a
n/a
--
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
n/a
n/a
n/a
0.5
n/a
n/a
n/a
--
n/a
n/a
n/a
10
Dedicated IV
Line
01:30
01:00 mg/mL
--
0.1
11
--
01:30
01:00
n/a
n/a
n/a
--
n/a
--
--
Intermittent Drugs - Critical Care
Available
As
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Drug Name
Therapy
Vanco Medford
zoledronic (ZOMETA)
P
X
X
X
X
X
X
X
X
X
X
X
S
------------
Duration Limits
Soft
Soft
Min
Max
01:00 02:30
00:30 03:30
00:30 01:30
01:00 02:30
00:30 03:30
00:30 01:30
-02:30
00:30 03:30
00:50 02:00
01:45 04:00
01:45 04:00
Initial
Value
01:30
-01:00
01:30
-01:00
01:30
-01:00
02:00
--
Concentration Limits
Conc. Hard
Soft
Soft
Units
Min
Min
Max
n/a
n/a
n/a
n/a
mg/mL
-1
6
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
mg/mL
-1
6
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
mg/mL
-0.5
5
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
mg/mL 0.4
-6
X
mg
210
2000
--
X
X
mg
210
2000
--
X
X
mg
50
600
--
X
X
mg/kg
1
2
--
--- mg / --- mL
X
--
--
00:50
01:30
01:00 mg/mL
X
X
mg
4
5
--
5 mg / 100 mL (0.05 mg / mL)
X
--
00:15
--
02:00
00:15
X
X
mg
2
4
--
4 mg / 100 mL (0.04 mg / mL)
--- mg / --- mL
X
X
---
00:15
00:15
---
02:00
02:00
00:15
n/a
00:15 mg/mL
VORIconazole
zoledronic (RECLAST)
Concentrations
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 200 mL (5 mg / mL)
--- mg / --- mL
200 mg / 250 mL (0.8 mg / mL)
400 mg / 250 mL (1.6 mg / mL)
--- mg / --- mL
Hard
Min
------01:00
-----
X
Vanco Wausau
zidovudine
Module
2.1.6 Fluids
Fluid Name
Therapy
..Maintenance IVF
.IVF + KCL 10 mEq/L
.IVF + KCL 20 mEq/L
.IVF + KCL 30 mEq/L
.IVF + KCL 40 mEq/L
.Maint IVF+Additives
Bicarb Drip
Blood (Cryoprecipit)
Blood (FFP)
Blood (platelets)
Blood (PRBCs)
Blood (whole)
Blood Reinfusion
CaCl 7353 mgINFUSION
CaGLUC 21,900 INFUS
Dextrose 10%
Epoprostenol Infusio
Hetastarch 6% NS
WVHN - 8/12/2011 08:17
Supports
Secondary
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
No
No
Yes
Yes
Yes
Yes
Yes
Fluids - Critical Care
Module
Rate Limits (mL/h)
P
S
Soft Soft Hard
Min
Max Max
X
-1
999
-X
-1
999
-X
-1
999
-X
-1
333
350
X
-1
250
275
X
-1
250
-X
-1
250
-X
X
10
300
-X
-20
300
-X
X
20
300
-X
-20
300
-X
-20
200
-X
-1
999
-X
X
30
85
-X
X
30
85
-X
-1
250
-X
-0.5
20
80
X
-1
999
--
Clinical Ads. Name
--------Dedicated IV Line
Dedicated IV Line
Dedicated IV Line
Dedicated IV Line
----Filter and light
--
Page 19 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
Clinical Ads.
Name
--
--
--
--
1
4
--
n/a
n/a
n/a
--
n/a
--
n/a
0.03
n/a
0.04
--
Fluid Name
Therapy
Lipids 20%
oxytocin POST PARTUM
Sodium Chlor 3%
Sodium Chloride 2%
Sodium Citrate 4%
TPN
TPN - Cyclic
Supports
Secondary
No
Yes
Yes
Yes
Yes
No
No
Fluids - Critical Care
Module
Rate Limits (mL/h)
P
S
Soft Soft Hard
Min
Max Max
X
-8
42
-X
-10
333
-X
X
1
50
75
X
X
1
75
100
X
X
100
210
-X
-15
175
250
X
-15
250
300
Clinical Ads. Name
------Central Line Only
2.1.7 PCA Drugs
Drug Name
Therapy
PCA Drugs - Critical Care
Concentrations:
600 mcg / 30 mL (20 mcg / mL)
fentaNYL
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
10
10
10
10
5
40
50
50
50
50
15
60
Hard Min
n/a
Hard
Initial
Max
Value
150
400
150
200
n/a
--
10
-n/a
n/a
8
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mcg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 20 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
PCA Drugs - Critical Care
Concentrations:
6 mg / 30 mL (0.2 mg / mL)
HYDROmorphone
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
Drug Name
Therapy
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
0.1
0.1
0.1
0.1
6
1
0.4
0.4
0.3
1
15
5
Hard Min
n/a
Hard
Initial
Max
Value
-1
--n/a
8
0.2
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
PCA Drugs - Critical Care
Concentrations:
300 mg / 30 mL (10 mg / mL)
meperidine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
6
n/a
5
5
10
10
8
40
30
25
300
20
15
300
Hard Min
n/a
Hard
Initial
Max
Value
50
50
-50
n/a
--
10
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 21 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
PCA Drugs - Critical Care
Concentrations:
30 mg / 30 mL (1 mg / mL)
morphine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
5
n/a
0.1
0.5
0.5
0.5
6
2
4
6
8
8
30
50
Hard Min
n/a
Hard
Initial
Max
Value
8
10
10
10
n/a
--
1
1
n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 22 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
2.2 L & D
2.2.1 Continuous/Bolus - Non-Anesthesia Drugs
Drug Name
Therapy
Concentrations
Module
P
S
--- unit / --- mL
insulin
Non-anesthesia
150 unit / 150 mL (1 unit / mL)
mag sulfate L&D
X
--
20 gram / 500 mL (0.04 gram / mL)
naloxone
X
0.8 mg / 250 mL (0.003 mg / mL)
4 mg / 1,000 mL (0.004 mg / mL)
--- mg / --- mL
oxytocin
X
X
X
30 unit / 500 mL (0.06 unit / mL)
Zidovudine infusion
X
--- mg / --- mL
zz AMINODArone
X
150 mg / 100 mL (1.5 mg / mL)
zz DOBUTamine
X
500 mg / 250 mL (2 mg / mL)
zz DOPamine
X
400 mg / 250 mL (1.6 mg / mL)
zz EPINEPHrine
X
4 mg / 250 mL (0.016 mg / mL)
X
heparin
WVHN - 8/12/2011 08:17
X
Continuous/Bolus - Non-Anesthesia Drugs - L & D
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
200
2500
3500
----unit/h
Conc.
Limits
Initial
Value
--
Bolus Dose Administration
Rate
Clinical Ads.
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----2nd RN to verify
n/a
Continuous
unit/h
0.1
25
50
--
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
gram/h
0.5
6
8
2
--
--
--
--
--
--
--
--
2nd RN to verify
0.064
3.9
--
--
--
--
--
--
--
--
--
--
--
Continuous
milliunit/min
0.5
40
300
--
--
--
--
--
--
--
--
--
--
YES Continuous
mg/kg/h
0.5
1.5
--
1
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/min
10
15
--
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mcg/kg/min
2.5
15
--
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mcg/kg/min
1
40
50
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mcg/kg/min
0.01
0.5
--
--
--
--
--
--
--
--
--
--
Code only drugs
--
-YES Continuous
mg/h
---n/a
--
--
--
--
--
--
Page 23 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Conc.
Limits
Module
P
S
zz lidocaine
2 gram / 500 mL (0.004 gram / mL)
n/a
X
--
zz NORepinephrine
n/a
4 mg / 250 mL (0.016 mg / mL)
zz PHENYLephrine
X
40 mg / 250 mL (0.16 mg / mL)
X
Continuous/Bolus - Non-Anesthesia Drugs - L & D
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.5
5
--0.5
3
-mg/min
Bolus Dose
mg/kg
Bolus Admin Rate
mg/min
Continuous
0.01
2
-----mcg/kg/min
Initial
Value
1.5
Bolus Dose Administration
Rate
Clinical Ads.
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
10
50
--Code only drugs
--
--
--
--
--
Code only drugs
--
--
--
--
--
Code only drugs
-n/a
Continuous
mcg/kg/min
0.02
9.5
--
--
--
--
--
--
2.2.2 Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - L & D
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
heparin
X
-unit/mL
50
-100
NonWeightBased
naloxone
X
--
mg/mL
--
0.001
0.006
NonWeightBased
Zidovudine infusion
X
--
mg/mL
--
1
4
WeightBased
2.2.3 Continuous/Bolus - Anesthesia Only Drugs
Drug Name
Therapy
Concentrations
Module
P
S
fentaNYL
50 mcg / 1 mL (50 mcg / mL)
WVHN - 8/12/2011 08:17
Conc.
Limits
n/a
--
X
Continuous/Bolus - Anesthesia Only Drugs - L & D
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
1
6
--0.5
6
-mcg/kg/h
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Page 24 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
0.5
1
---
Clinical Ads.
Name
--
Module
Drug Name
Therapy
Concentrations
P
insulin
Anesthesia only
150 unit / 150 mL (1 unit / mL)
Propofol ANESTHESIA
Conc.
Limits
S
n/a
X
-X
X
X
---
remifentanil
n/a
50 mcg / 1 mL (50 mcg / mL)
--
X
SUFentanil
n/a
50 mcg / 1 mL (50 mcg / mL)
--
Initial
Value
--
Bolus Dose Administration
Clinical Ads.
Rate
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----2nd RN to verify
-n/a
10 mg / 1 mL (10 mg / mL)
500 mg / 50 mL (10 mg / mL)
1,000 mg / 100 mL (10 mg / mL)
Continuous/Bolus - Anesthesia Only Drugs - L & D
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.1
25
75
----unit/h
X
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
mcg/kg/h
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
5
300
--
--
100
3000
--
--
100
1500
--
--
--
0.125
1.5
--
--
0.25
1
--
--
0.25
1.5
--
--
--
0.1
2
--
--
0.5
5
--
--
0.5
2.5
--
--
--
2.2.4 Continuous/Bolus - Anesthesia Only Drugs - Concentration Limits
No drugs exist in this section.
2.2.5 Intermittent Drugs
Intermittent Drugs - L & D
Available
As
Drug Name
Therapy
acyclovir
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
mg
100
2000
X
gram
0.2
3
X
WVHN - 8/12/2011 08:17
gram
0.1
3
P
S
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
--- mg / --- mL
X
--
--
00:45
02:00
01:00 mg/mL
--
0.5 gram / 50 mL (0.01 gram / mL)
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
----
----
00:25
00:25
00:25
01:00
01:00
01:00
00:30
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1.5 gram / 50 mL (0.03 gram / mL)
3 gram / 100 mL (0.03 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
ampicillin/sulbact
X
Concentrations
Hard
Min
--
ampicillin
X
Module
4.5
Page 25 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
n/a
n/a
n/a
n/a
n/a
n/a
gram/m
0.005
L
n/a
n/a
n/a
n/a
gram/m
0.015
L
Clinical Ads.
Name
0.5
7
--
n/a
n/a
n/a
n/a
n/a
n/a
--
--
0.1
n/a
n/a
n/a
n/a
--
0.45
--
Intermittent Drugs - L & D
Available
As
Drug Name
Therapy
azithromycin
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
mg
250
500
--
X
X
gram
0.25
2
--
aztreonam
calcium gluconate
X
X
mg
500
2000
--
X
X
gram
0.25
2
--
ceFAZolin
cefePIME
X
X
gram
0.25
2
--
cefoTAXime
X
X
gram
0.25
2
--
cefOXitin
X
X
gram
0.5
2
--
cefTAZidime
X
X
gram
0.5
2
--
cefTRIAXone
X
chlorothiazide
CIPROfloxacin
X
gram
0.125
2
--
X
X
mg
250
2000
--
X
X
mg
200
400
--
X
X
mg
50
900
--
X
X
mg
250
500
--
CLINDAmycin
DAPTOmycin
WVHN - 8/12/2011 08:17
Module
Duration Limits
Soft
Soft
Min
Max
-03:00
-03:00
00:25 01:00
00:25 01:00
Concentration Limits
Initial Conc. Hard
Soft
Soft
Value Units
Min
Min
Max
01:00
n/a
n/a
n/a
n/a
01:00 mg/mL
-0.5
2.5
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
0.001
-0.2
L
01:00
n/a
n/a
n/a
n/a
01:00 mg/mL
-10
200
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
gram/m
00:30
-0.01
0.04
L
Concentrations
500 mg / 250 mL (2 mg / mL)
--- mg / --- mL
1 gram / 100 mL (0.01 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
P
X
X
X
X
S
-----
Hard
Min
00:50
00:50
---
--- gram / --- mL
X
--
--
00:25
01:00
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
X
-----
00:10
00:10
---
00:45
00:45
00:25
00:25
06:00
06:00
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
--- gram / --- mL
X
--
--
00:25
01:00
--- mg / --- mL
X
--
--
00:15
02:00
00:30 mg/mL
--
1
30
200 mg / 100 mL (2 mg / mL)
400 mg / 200 mL (2 mg / mL)
300 mg / 50 mL (6 mg / mL)
600 mg / 50 mL (12 mg / mL)
900 mg / 50 mL (18 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
X
X
---------
---------
00:50
00:50
00:10
00:20
00:20
00:10
00:25
00:25
02:00
02:00
01:00
01:00
01:00
01:00
01:00
01:00
01:00
n/a
01:00
n/a
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
00:30
n/a
00:30 mg/mL
n/a
n/a
n/a
n/a
n/a
-n/a
2
n/a
n/a
n/a
n/a
n/a
3
n/a
--
n/a
n/a
n/a
n/a
n/a
18
n/a
15
Page 26 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Clinical Ads.
Name
--
--
--
--
--
--
--
--
--
---
--
--
Intermittent Drugs - L & D
Available
As
Drug Name
Therapy
desmopressin
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Estrogen, conjugated
P
S
--- mcg / --- mL
X
--
--
00:15
01:00
00:30 mcg/mL
1 gram / 50 mL (0.02 gram / mL)
X
--
--
00:25
02:00
00:30
--- gram / --- mL
X
--
--
00:25
02:00
--
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
---
---
00:30
00:30
25
--
25 mg / 50 mL (0.5 mg / mL)
X
--
--
62.5
500
--
mg
25
2000
--
X
mg
40
800
--
X
X
mg
100
1000
--
125 mg / 100 mL (1.25 mg / mL)
250 mg / 250 mL (1 mg / mL)
--- mg / --- mL
100 mg / 50 mL (2 mg / mL)
--- mg / --- mL
80 mg / 100 mL (0.8 mg / mL)
--- mg / --- mL
250 mg / 100 mL (2.5 mg / mL)
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
X
X
X
X
X
------------
X
X
mg
100
2000
--
--- mg / --- mL
X
X
mcg/kg
0.25
0.35
--
X
X
gram
0.45
1.25
--
X
X
mg
100
1000
X
X
mg
5
X
X
mg
X
X
X
ferric gluconate Na
fosphenytoin
gentamicin
imipenem/cilastatin
iron DEXTRAN
iron sucrose
Magnesium bolus L&D
4
n/a
n/a
n/a
--
0.01
0.02
02:00
02:00
n/a
gram/m
00:30
L
01:30
n/a
01:30 mg/mL
n/a
--
n/a
1
n/a
5
--
00:15
00:45
00:30
n/a
n/a
n/a
n/a
--
-----00:25
00:45
-----
00:10
00:20
01:00
00:10
00:10
--00:25
00:25
00:50
00:25
00:30
02:30
03:00
00:30
00:30
01:20
01:20
01:00
01:00
02:00
02:00
00:15
02:00
-00:20
00:20
01:00
01:00
00:30
00:30
01:00
--
n/a
n/a
mg/mL
n/a
mg/mL
n/a
mg/mL
n/a
n/a
n/a
mg/mL
n/a
n/a
-n/a
-n/a
0.5
n/a
n/a
n/a
--
n/a
n/a
1
n/a
1.5
n/a
-n/a
n/a
n/a
2
n/a
n/a
5
n/a
25
n/a
10
n/a
n/a
n/a
5
--
mg/mL
--
01:00
01:30
04:00
--
2
4
------X
----
----00:10
00:10
00:10
----
00:06
00:15
01:00
00:15
---00:50
00:50
01:15
01:00
01:00
02:00
05:00
00:30
00:30
00:30
02:00
02:00
02:00
00:15
n/a
00:30
n/a
01:30
n/a
-mg/mL
00:15
n/a
00:15
n/a
00:15 mg/mL
01:00
n/a
01:00
n/a
01:30
n/a
n/a
n/a
n/a
-n/a
n/a
-n/a
n/a
n/a
n/a
n/a
n/a
0.2
n/a
n/a
2.5
n/a
n/a
n/a
n/a
n/a
n/a
2.1
n/a
n/a
15
n/a
n/a
n/a
600 mg / 300 mL (2 mg / mL)
X
--
00:45
--
02:00
01:00
n/a
n/a
n/a
4 gram / 100 mL (0.04 gram / mL)
6 gram / 100 mL (0.06 gram / mL)
500 mg / 50 mL (10 mg / mL)
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
250 mg / 50 mL (5 mg / mL)
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
X
X
---------
00:20
00:20
-------
--00:25
00:25
00:25
00:25
00:25
00:50
02:00
02:00
01:00
01:00
01:00
02:00
02:00
02:00
00:30
n/a
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
00:30
n/a
00:30
n/a
01:00 mg/mL
n/a
n/a
n/a
n/a
-n/a
n/a
--
n/a
n/a
n/a
n/a
2
n/a
n/a
2
n/a
n/a
n/a
n/a
4
n/a
n/a
5
25
X
X
mg
250
X
X
mg
250
X
X
mg
400
800
--
X
X
gram
2
6
--
X
X
mg
250
4000
--
X
X
mg
250
1000
--
meropenem
metroNIDAZOLE
WVHN - 8/12/2011 08:17
0.01
X
X
X
X
X
X
X
X
X
X
mg
Page 27 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Clinical Ads.
Name
--
X
X
levoFLOXacin
Concentrations
100 mg / 100 mL (1 mg / mL)
200 mg / 100 mL (2 mg / mL)
500
-300 mg / 250 mL (1.2 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1500 3000 1,000 mg / 100 mL (10 mg / mL)
--- mg / --- mL
250 mg / 50 mL (5 mg / mL)
750
-- 500 mg / 100 mL (5 mg / mL)
750 mg / 150 mL (5 mg / mL)
X
levETIRAcetam
linezolid
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
ertapenem
erythromycin
Module
n/a
---
----
--
--
Hypersensitivity
--
-----
--
Intermittent Drugs - L & D
Available
As
Drug Name
Therapy
moxifloxacin
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
mg
300
500
--
nafcillin
X
penG 2.5 Mill Units
penG 5 million units
Penicillin G
phenytoin
Loading Dose
phenytoin
Maintenance Dose
Pip/Tazo Extended
X
gram
0.2
2
--
potassium chloride
Peripheral
potassium PHOSphate
Central
potassium PHOSphate
Peripheral
P
S
400 mg / 250 mL (1.6 mg / mL)
X
--
--
00:30
02:00
01:00
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:30
01:30
00:30
01:00
--- gram / --- mL
X
--
--
00:25
01:30
Concentrations
n/a
n/a
n/a
n/a
n/a
n/a
gram/m
00:30
L
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
Clinical Ads.
Name
--
--
X
unit
2
3
--
2.5 unit / 100 mL (0.025 unit / mL)
X
--
--
00:25
01:00
00:30
n/a
n/a
n/a
n/a
1unit=1million
X
X
unit
4.5
5.5
--
5 unit / 250 mL (0.02 unit / mL)
X
--
--
00:25
02:00
00:30
n/a
n/a
n/a
n/a
1unit=1million
X
X
unit
1
5
--
--- unit / --- mL
X
--
--
00:25
01:00
00:30 unit/mL
0.02
--
0.05
1unit=1million
X
X
mg/kg
5
25
--
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
1
10
X
X
mg/kg
0.5
2.5
--
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
1
10
X
X
gram
3
4
--
3.37 gram / 50 mL (0.067 gram / mL)
X
--
--
03:45
04:30
04:00
n/a
n/a
n/a
n/a
2.25 gram / 50 mL (0.045 gram / mL)
3.37 gram / 50 mL (0.067 gram / mL)
4.5 gram / 100 mL (0.045 gram / mL)
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
X
X
X
------
---00:30
01:00
00:25
00:25
00:25
00:45
01:30
01:00
01:00
01:00
02:00
04:00
00:30
00:30
00:30
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
--- mEq / --- mL
X
--
00:50
01:00
04:00
--
0.1
--
0.4
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
---
00:45
01:30
---
03:00
06:00
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
--- mEq / --- mL
X
--
00:50
--
04:00
--
0.1
--
0.2
14 mmol / 250 mL (0.056 mmol / mL)
15 mmol / 100 mL (0.15 mmol / mL)
X
X
---
02:00
02:00
---
06:00
06:00
03:00
03:00
n/a
n/a
n/a
n/a
n/a
n/a
--- mmol / --- mL
X
--
03:00
--
09:00
04:00
--
0.01
0.24
14 mmol / 250 mL (0.056 mmol / mL)
X
--
02:00
--
06:00
03:00
--- mmol / --- mL
X
--
02:00
--
06:00
--
n/a
n/a
n/a
n/a
n/a
mEq/m
L
n/a
n/a
mEq/m
L
n/a
n/a
mmol/m
L
n/a
mmol/m
L
n/a
n/a
mg/mL
X
X
gram
0.75
4.5
--
X
X
mEq
5
60
--
X
X
X
X
mEq
mmol
5
14
40
40
--
--
X
X
mmol
10
30
--
X
X
mg
100
600
--
300 mg / 250 mL (1.2 mg / mL)
600 mg / 500 mL (1.2 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:50
00:50
00:55
03:00
03:00
03:00
01:00
01:00
--
X
X
mg/kg
1.5
6
--
--- mg / --- mL
X
--
00:45
--
02:00
01:00 mg/mL
15 mmol / 250 mL (0.06 mmol / mL)
X
--
02:00
--
06:00
03:00
X
X
mmol
10
60
--
--- mmol / --- mL
X
--
02:00
--
06:00
--
rifampin
SMX/TMP
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
X
piperacillin/tazo
potassium chloride
Central
Module
sodium phosphate
WVHN - 8/12/2011 08:17
Page 28 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
mmol/m
L
Filter 0.22
Micron
Filter 0.22
Micron
---
--
--
--
n/a
n/a
n/a
--
0.01
0.07
n/a
n/a
--
n/a
n/a
0.1
n/a
n/a
6
--
--
0.1
1.2
48 Hour Tubing
n/a
n/a
n/a
--
0.03
0.3
--
--
Intermittent Drugs - L & D
Available
As
Drug Name
Therapy
ticarcillin/clav
tigeCYCLINE
TOBRAmycin
valproate sodium
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
gram
2
3.1
--
X
X
mg
25
100
--
X
X
mg
40
600
--
X
X
mg
250
2000
--
Vanco Langlade
X
X
mg
210
2000
--
X
X
mg
210
2000
--
X
X
mg
210
2000
--
X
X
mg
50
600
--
X
X
mg/kg
1
2
--
Vanco Medford
Vanco Wausau
VORIconazole
zidovudine
Module
P
S
3.1 gram / 100 mL (0.031 gram / mL)
X
--
--
00:25
01:00
00:30
50 mg / 50 mL (1 mg / mL)
100 mg / 100 mL (1 mg / mL)
80 mg / 100 mL (0.8 mg / mL)
--- mg / --- mL
X
X
X
X
-----
--00:25
00:25
00:25
00:25
---
01:00
01:00
01:00
01:00
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
--- mg / --- mL
X
--
--
00:50
01:30
01:00 mg/mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 200 mL (5 mg / mL)
--- mg / --- mL
200 mg / 250 mL (0.8 mg / mL)
400 mg / 250 mL (1.6 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
X
X
X
X
X
X
-------------
-------01:00
-----
00:30
01:00
00:30
00:30
01:00
00:30
00:30
-00:30
00:50
01:45
01:45
01:30
02:30
03:30
01:30
02:30
03:30
01:30
02:30
03:30
02:00
04:00
04:00
01:00
01:30
-01:00
01:30
-01:00
01:30
-01:00
02:00
--
--- mg / --- mL
X
--
--
00:50
01:30
01:00 mg/mL
Concentrations
2.2.6 Fluids
Fluid Name
Therapy
..Maintenance IVF
.IVF + KCL 10 mEq/L
.IVF + KCL 20 mEq/L
.IVF + KCL 30 mEq/L
.IVF + KCL 40 mEq/L
.Maint IVF+Additives
AmNIOinfusion
Blood (Cryoprecipit)
Blood (FFP)
Blood (platelets)
Blood (PRBCs)
Blood (whole)
Dextrose 10%
WVHN - 8/12/2011 08:17
Supports
Secondary
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
No
Yes
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
Fluids - L & D
Module
Rate Limits (mL/h)
P
S
Soft Soft Hard
Min
Max Max
X
-1
999
-X
-1
999
-X
-1
999
-X
-1
333
350
X
-1
250
275
X
-1
250
-X
X
50
650
-X
X
10
300
-X
-20
300
-X
X
20
300
-X
-20
300
-X
-20
200
-X
-1
250
--
Clinical Ads. Name
--------Dedicated IV Line
Dedicated IV Line
Dedicated IV Line
Dedicated IV Line
--
Page 29 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
n/a
n/a
mg/mL
n/a
n/a
mg/mL
n/a
n/a
mg/mL
n/a
n/a
mg/mL
Clinical Ads.
Name
n/a
n/a
n/a
--
n/a
n/a
n/a
0.5
n/a
n/a
n/a
--
n/a
n/a
n/a
10
Dedicated IV
Line
--
--
0.1
11
n/a
n/a
-n/a
n/a
-n/a
n/a
-n/a
n/a
0.4
n/a
n/a
1
n/a
n/a
1
n/a
n/a
0.5
n/a
n/a
--
n/a
n/a
6
n/a
n/a
6
n/a
n/a
5
n/a
n/a
6
--
1
4
--
--
--
--
---
2.2.7 PCA Drugs
Drug Name
Therapy
PCA Drugs - L & D
Concentrations:
600 mcg / 30 mL (20 mcg / mL)
fentaNYL
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
Drug Name
Therapy
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
10
10
10
10
5
40
50
50
50
50
15
60
Hard Min
n/a
Hard
Initial
Max
Value
150
400
150
200
n/a
--
10
-n/a
n/a
8
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mcg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
PCA Drugs - L & D
Concentrations:
6 mg / 30 mL (0.2 mg / mL)
HYDROmorphone
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
0.1
0.1
0.1
0.1
6
1
0.4
0.4
0.3
1
15
5
Hard Min
n/a
Hard
Initial
Max
Value
-1
--n/a
8
0.2
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 30 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
PCA Drugs - L & D
Concentrations:
300 mg / 30 mL (10 mg / mL)
meperidine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
Drug Name
Therapy
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
6
n/a
5
5
10
10
8
40
30
25
300
20
15
300
Hard Min
n/a
Hard
Initial
Max
Value
50
50
-50
n/a
--
10
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
PCA Drugs - L & D
Concentrations:
30 mg / 30 mL (1 mg / mL)
morphine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
5
n/a
0.1
0.5
0.5
0.5
6
2
4
6
8
8
30
50
Hard Min
n/a
Hard
Initial
Max
Value
8
10
10
10
n/a
--
1
1
n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 31 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
2.3 Med Surg
2.3.1 Continuous/Bolus - Non-Anesthesia Drugs
Drug Name
Therapy
Concentrations
Module
P
S
AMINOphyllineINFUSIO
1,000 mg / 1,000 mL (1 mg / mL)
argatroban
.Standard Dosing
125 mg / 125 mL (1 mg / mL)
argatroban
Hepatic Dose
125 mg / 125 mL (1 mg / mL)
bivalirudin
.Standard Dosing
250 mg / 50 mL (5 mg / mL)
bivalirudin
Renal Dose
250 mg / 50 mL (5 mg / mL)
n/a
X
X
X
X
X
X
400 mg / 250 mL (1.6 mg / mL)
--- mg / --- mL
fentaNYL
X
X
2,000 mcg / 100 mL (20 mcg / mL)
X
Clinical Ads.
Name
--
Continuous
mcg/kg/min
0.45
10
10.1
1.5
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mcg/kg/min
0.1
5
10.1
0.5
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mg/kg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Continuous
mg/kg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Continuous
mg/h
0.095
1.8
--
1.75
0.3
0.76
--
0.75
0.3
0.76
--
0.75
--
0.24
1.1
--
1
0.3
0.76
--
0.75
0.3
0.76
--
0.75
--
0.1
4
8
--
--
--
--
--
--
--
--
--
--
1
40
50
--
--
--
--
--
--
--
--
--
Central Line
Only
10
100
--
--
25
100
--
--
12.5
50
--
--
--
--
--
--
--
n/a
25 mg / 100 mL (0.25 mg / mL)
50 mg / 200 mL (0.25 mg / mL)
DOPamine
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
n/a
n/a
X
Continuous/Bolus - Non-Anesthesia Drugs - Med Surg
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
10
40
60
----mg/h
--
bumetanide continuos
WVHN - 8/12/2011 08:17
Conc.
Limits
--YES Continuous
mcg/kg/min
--n/a
--
Continuous
mcg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
Page 32 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Module
P
S
FUROSemide
1,000 mg / 100 mL (10 mg / mL)
--- mg / --- mL
heparin
X
X
--- unit / --- mL
insulin
Non-anesthesia
150 unit / 150 mL (1 unit / mL)
--- unit / --- mL
IVIG 10%
X
5 gram / 50 mL (0.1 gram / mL)
10 gram / 100 mL (0.1 gram / mL)
20 gram / 200 mL (0.1 gram / mL)
lepirudin
.Standard Dosing
100 mg / 250 mL (0.4 mg / mL)
lepirudin
Weight above 110kg
100 mg / 250 mL (0.4 mg / mL)
morphine
X
X
X
100 mg / 100 mL (1 mg / mL)
250 mg / 250 mL (1 mg / mL)
500 mg / 500 mL (1 mg / mL)
--- mg / --- mL
naloxone
X
X
X
X
0.8 mg / 250 mL (0.003 mg / mL)
4 mg / 1,000 mL (0.004 mg / mL)
--- mg / --- mL
octreotide
X
X
X
1,500 mcg / 500 mL (3 mcg / mL)
--- mcg / --- mL
X
X
X
X
X
X
X
--- mg / --- mL
X
WVHN - 8/12/2011 08:17
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
Clinical Ads.
Name
--
--YES Continuous
unit/h
200
2500
3500
--
--
--
--
--
--
--
--
--
2nd RN to verify
YES Continuous
unit/h
0.1
25
75
--
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mg/kg/h
25
250
480
50
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/kg/h
0.01
0.2
0.3
--
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mg/h
16.4
16.6
16.7
16.5
--
--
--
--
--
--
--
--
2nd RN to verify
YES Continuous
mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
YES Continuous
mg/h
0.5
25
--
--
0.5
10
--
--
0.25
2
--
--
--
0.064
3.9
--
--
--
--
--
--
--
--
--
--
--
YES Continuous
mcg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
n/a Continuous
mg/h
25
75
--
50
25
175
--
--
12
25
--
12.5
--
7
9
--
8
--
--
--
--
--
--
--
--
--
YES Continuous
mg/kg/h
0.5
1.5
--
1
--
--
--
--
--
--
--
--
--
--
---
----
--
--
-----
----
---
pantoprazole
80 mg / 100 mL (0.8 mg / mL)
Zidovudine infusion
Continuous/Bolus - Non-Anesthesia Drugs - Med Surg
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
1
80
160
----mg/h
Conc.
Limits
--
--
Page 33 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Conc.
Limits
Module
P
S
zz AMINODArone
n/a
150 mg / 100 mL (1.5 mg / mL)
zz DOBUTamine
X
500 mg / 250 mL (2 mg / mL)
zz DOPamine
X
400 mg / 250 mL (1.6 mg / mL)
zz EPINEPHrine
X
4 mg / 250 mL (0.016 mg / mL)
zz lidocaine
X
2 gram / 500 mL (0.004 gram / mL)
X
n/a
Continuous
mcg/kg/min
2.5
15
--
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mcg/kg/min
1
40
50
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mcg/kg/min
0.01
0.5
--
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mg/min
Bolus Dose
mg/kg
Bolus Admin Rate
mg/min
Continuous
mcg/kg/min
0.5
5
--
--
0.5
3
--
1.5
10
50
--
--
Code only drugs
0.01
2
--
--
--
--
--
--
--
--
--
--
Code only drugs
0.02
9.5
--
--
--
--
--
--
--
--
--
--
Code only drugs
--
--
--
--
n/a
X
40 mg / 250 mL (0.16 mg / mL)
X
-n/a
Continuous
mcg/kg/min
--
2.3.2 Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Med Surg
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
DOPamine
X
-mcg/mL
-0.8
3.2
WeightBased
FUROSemide
X
--
mg/mL
1
5
11
NonWeightBased
heparin
X
--
unit/mL
50
--
100
X
--
unit/mL
--
0.2
1.5
NonWeightBased
insulin
Non-anesthesia
NonWeightBased
WVHN - 8/12/2011 08:17
Initial
Value
--
Bolus Dose Administration
Rate
Clinical Ads.
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----Code only drugs
--
zz NORepinephrine
4 mg / 250 mL (0.016 mg / mL)
zz PHENYLephrine
Continuous/Bolus - Non-Anesthesia Drugs - Med Surg
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
10
15
-----mg/min
Page 34 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Med Surg
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
morphine
X
-mg/mL
-1
1.5
NonWeightBased
naloxone
X
--
mg/mL
--
0.001
0.006
NonWeightBased
octreotide
X
--
mcg/mL
--
1
6
NonWeightBased
Zidovudine infusion
X
--
mg/mL
--
1
4
WeightBased
2.3.3 Continuous/Bolus - Anesthesia Only Drugs
Drug Name
Therapy
Concentrations
insulin
Anesthesia only
150 unit / 150 mL (1 unit / mL)
Propofol ANESTHESIA
10 mg / 1 mL (10 mg / mL)
500 mg / 50 mL (10 mg / mL)
1,000 mg / 100 mL (10 mg / mL)
Module
P
S
n/a
X
n/a
-X
X
X
--n/a
--
X
rocuronium
10 mg / 1 mL (10 mg / mL)
WVHN - 8/12/2011 08:17
n/a
--
Continuous/Bolus - Anesthesia Only Drugs - Med Surg
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.1
25
75
----unit/h
Initial
Value
--
Bolus Dose Administration
Clinical Ads.
Rate
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----2nd RN to verify
--
remifentanil
50 mcg / 1 mL (50 mcg / mL)
Conc.
Limits
X
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
5
300
--
--
100
3000
--
--
100
1500
--
--
--
0.125
1.5
--
--
0.25
1
--
--
0.25
1.5
--
--
--
1
20
--
--
10
1200
--
--
10
1200
--
--
--
Page 35 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Module
Drug Name
Therapy
Concentrations
P
Conc.
Limits
S
SUFentanil
n/a
50 mcg / 1 mL (50 mcg / mL)
--
X
vecuronium
n/a
1 mg / 1 mL (1 mg / mL)
--
X
Continuous/Bolus - Anesthesia Only Drugs - Med Surg
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.1
2
--0.5
5
-mcg/kg/h
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
0.01
2.5
--5
120
-mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Initial
Value
--
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
0.5
2.5
---
5
120
--
--
Clinical Ads.
Name
--
Neuromuscular
BA
2.3.4 Continuous/Bolus - Anesthesia Only Drugs - Concentration Limits
No drugs exist in this section.
2.3.5 Intermittent Drugs
Intermittent Drugs - Med Surg
Available
As
Drug Name
Therapy
acetaZOLAMIDE
acetylcysteine
First Dose
acetylcysteine
Second Dose
acetylcysteine
Third Dose
acyclovir
albumin 25%
albumin 5%
ampho B
(LIPOSOMAL)
amphotericin B
.Standard Dosing
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
P
S
Hard
Min
X
X
mg
100
1000
--
--- mg / --- mL
X
--
--
00:15
01:00
00:30 mg/mL
--
10
100
--
X
X
mg/kg
140
160
--
--- mg / --- mL
X
--
--
00:30
02:00
01:00 mg/mL
1
--
75
--
X
X
mg/kg
40
60
--
--- mg / --- mL
X
--
--
03:30
05:00
04:00 mg/mL
1
--
75
--
X
X
mg/kg
90
110
--
--- mg / --- mL
X
--
--
13:20
18:00
16:00 mg/mL
1
--
75
--
X
X
mg
100
2000
--
--- mg / --- mL
X
--
--
00:45
02:00
01:00 mg/mL
--
0.5
7
--
X
X
---
---
00:15
00:20
01:00
01:00
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
--
--
n/a
n/a
n/a
n/a
--
--
0.2
2
--
--
0.05
0.25
Protect From
Light
Concentrations
X
X
gram
12.5
25
--
12.5 gram / 50 mL (0.25 gram / mL)
25 gram / 100 mL (0.25 gram / mL)
X
X
gram
12.5
13
--
12.5 gram / 250 mL (0.05 gram / mL)
X
--
--
00:10
01:00
X
X
mg/kg
2.8
5.5
--
--- mg / --- mL
X
--
--
01:00
04:00
X
X
mg
1
100
--
--- mg / --- mL
X
--
00:59
--
06:00
WVHN - 8/12/2011 08:17
Page 36 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
02:00 mg/mL
--
mg/mL
Intermittent Drugs - Med Surg
Available
As
Drug Name
Therapy
amphotericin B
Blasto load < 100 KG
amphotericin B
Blasto load >= 100KG
amphotericin B
Blasto Maintenance
ampicillin
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
P
S
0.6 --- mg / --- mL
X
--
--
02:30
03:30
03:00 mg/mL 0.009
0.09
0.25
50
55
50 mg / 500 mL (0.1 mg / mL)
X
--
--
02:30
03:30
03:00
n/a
n/a
n/a
0.9
1
--- mg / --- mL
X
--
22:00
23:00
25:00
24:00 mg/mL
--
0.009
0.25
--
0.5 gram / 50 mL (0.01 gram / mL)
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
----
----
00:25
00:25
00:25
01:00
01:00
01:00
00:30
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1.5 gram / 50 mL (0.03 gram / mL)
3 gram / 100 mL (0.03 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
500 mg / 250 mL (2 mg / mL)
--- mg / --- mL
1 gram / 100 mL (0.01 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
X
-----
00:50
00:50
---
--00:25
00:25
03:00
03:00
01:00
01:00
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
X
X
X
-------
--00:10
00:10
---
00:08
00:08
00:45
00:45
00:25
00:25
02:00
02:00
06:00
06:00
01:00
01:00
01:00
01:00
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
X
mg/kg
0.45
0.55
X
X
mg
45
X
X
mg/kg
0.6
X
gram
0.2
3
ampicillin/sulbact
X
azithromycin
X
gram
0.1
3
4.5
X
X
mg
250
500
--
X
X
gram
0.25
2
--
aztreonam
calcium chloride
calcium gluconate
X
X
mg
500
1000 1500
X
X
mg
500
2000
--
X
X
gram
0.25
2
--
ceFAZolin
cefePIME
X
X
gram
0.25
2
--
cefoTAXime
X
X
gram
0.25
2
--
cefOXitin
X
cefTAZidime
X
X
X
WVHN - 8/12/2011 08:17
gram
gram
0.5
0.5
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
X
X
Module
2
2
--
--
Concentrations
Page 37 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
n/a
n/a
n/a
n/a
n/a
n/a
gram/m
0.005
L
n/a
n/a
n/a
n/a
gram/m
0.015
L
n/a
n/a
mg/mL
-n/a
n/a
n/a
n/a
gram/m
0.001
L
n/a
n/a
mg/mL
10
n/a
n/a
mg/mL
-n/a
n/a
n/a
n/a
gram/m
-L
n/a
n/a
n/a
n/a
gram/m
-L
n/a
n/a
n/a
n/a
gram/m
-L
n/a
n/a
n/a
n/a
gram/m
-L
n/a
n/a
n/a
n/a
--
0.1
n/a
n/a
n/a
n/a
--
0.45
n/a
0.5
n/a
n/a
n/a
2.5
n/a
n/a
--
0.2
n/a
-n/a
10
n/a
n/a
n/a
100
n/a
200
n/a
n/a
0.01
0.04
n/a
n/a
n/a
n/a
0.01
0.04
n/a
n/a
n/a
n/a
0.01
0.04
n/a
n/a
n/a
n/a
0.01
0.04
n/a
n/a
n/a
n/a
Clinical Ads.
Name
Protect From
Light
Protect From
Light
Protect From
Light
--
--
--
-Central Line
Only
--
--
--
--
--
--
Intermittent Drugs - Med Surg
Available
As
Drug Name
Therapy
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
cefTRIAXone
X
chlorothiazide
CIPROfloxacin
X
gram
0.125
2
--
DAPTOmycin
desmopressin
doxyCYCLINE
--
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
--- gram / --- mL
X
--
--
--- mg / --- mL
X
--
--
00:15
02:00
00:30 mg/mL
--
1
30
200 mg / 100 mL (2 mg / mL)
400 mg / 200 mL (2 mg / mL)
300 mg / 50 mL (6 mg / mL)
600 mg / 50 mL (12 mg / mL)
900 mg / 50 mL (18 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
-------
-------
00:50
00:50
00:10
00:20
00:20
00:10
02:00
02:00
01:00
01:00
01:00
01:00
01:00
n/a
01:00
n/a
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
n/a
n/a
n/a
n/a
n/a
--
n/a
n/a
n/a
n/a
n/a
3
n/a
n/a
n/a
n/a
n/a
18
--
2000
--
X
X
mg
200
400
--
X
X
mg
50
900
--
X
X
mg/kg
1
2.5
--
--- mg / --- mL
X
--
--
00:50
03:00
01:00 mg/mL
--
0.1
0.35
--
X
X
mg
250
500
--
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
---
---
00:25
00:25
01:00
01:00
00:30
n/a
00:30 mg/mL
n/a
2
n/a
--
n/a
15
--
X
X
mcg/kg
0.25
0.35
--
--- mcg / --- mL
X
--
--
00:15
01:00
00:30 mcg/mL
--
0.01
4
--
X
X
mg
25
200
--
100 mg / 250 mL (0.4 mg / mL)
--- mg / --- mL
1 gram / 50 mL (0.02 gram / mL)
X
X
X
----
----
00:45
00:45
00:25
04:00
04:00
02:00
n/a
-n/a
n/a
0.1
n/a
n/a
1
n/a
X
X
gram
0.45
1.25
--
--- gram / --- mL
X
--
--
00:25
02:00
--
0.01
0.02
X
X
mg
X
X
mg
X
X
mg
X
X
mg
X
X
mg
X
X
mg/kg
X
X
mg
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
-------------------
-----------00:25
00:25
00:25
--00:25
00:45
00:30
00:30
00:10
00:20
01:00
00:30
00:30
00:30
00:30
00:10
00:10
---00:50
00:50
---
02:00
02:00
00:30
02:30
03:00
04:00
04:00
04:00
04:00
00:30
00:30
00:45
00:45
00:45
02:00
02:00
01:20
01:20
01:00
n/a
01:00 mg/mL
00:30
n/a
gram/m
00:30
L
01:30
n/a
01:30 mg/mL
00:15
n/a
02:00
n/a
-mg/mL
01:00
n/a
01:00
n/a
02:00
n/a
-mg/mL
00:20
n/a
00:20 mg/mL
00:30
n/a
00:30
n/a
00:30 mg/mL
01:00
n/a
01:00 mg/mL
01:00
n/a
01:00 mg/mL
n/a
-n/a
n/a
-n/a
n/a
n/a
-n/a
-n/a
n/a
0.5
n/a
-n/a
0.5
n/a
1
n/a
n/a
1
n/a
n/a
n/a
1
n/a
1.5
n/a
n/a
-n/a
1
n/a
--
n/a
5
n/a
n/a
5
n/a
n/a
n/a
2
n/a
25
n/a
n/a
7
n/a
10
n/a
10
furosemide in HSS
gentamicin
--
250
fluCONazole
GANcyclovir
S
X
Concentrations
mg
ferric gluconate Na
fosphenytoin
P
--- gram / --- mL
Clinical Ads.
Name
X
ertapenem
erythromycin
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
gram/m
00:25 01:00 00:30
-0.01
0.04
L
00:25 01:00 00:30
n/a
n/a
n/a
n/a
00:25 01:00 00:30
n/a
n/a
n/a
n/a
gram/m
00:25 01:00 00:30
-0.01
0.04
L
Hard
Min
X
CLINDAmycin
dantrolene
Module
WVHN - 8/12/2011 08:17
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
125 mg / 100 mL (1.25 mg / mL)
62.5 500
-- 250 mg / 250 mL (1 mg / mL)
--- mg / --- mL
100 mg / 50 mL (2 mg / mL)
200 mg / 100 mL (2 mg / mL)
50
800
-400 mg / 200 mL (2 mg / mL)
--- mg / --- mL
100 mg / 50 mL (2 mg / mL)
25 2000
---- mg / --- mL
250 mg / 150 mL (1.667 mg / mL)
100 500 1000 500 mg / 150 mL (3.333 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
0.625
8
---- mg / --- mL
80 mg / 100 mL (0.8 mg / mL)
40
800
---- mg / --- mL
100
1000
--
Page 38 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
---
--
-----
--
-----
Intermittent Drugs - Med Surg
Available
As
Drug Name
Therapy
imipenem/cilastatin
inFLIXimab
iron DEXTRAN
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
100
1000
--
X
X
mg/kg
2
10
--
--- mg / --- mL
X
--
--
01:55
25:00
X
X
mg
100
2000
--
--- mg / --- mL
X
X
mg
25
X
X
mg
250
X
X
mg
250
X
X
mg
400
--
mg/mL
--
mg/mL
--
0.4
Clinical Ads.
Name
--
4
Hypersensitivity
--
X
--
01:00
01:30
04:00
--
2
4
X
X
X
X
X
X
X
X
X
X
------X
----
----00:10
00:10
00:10
----
00:06
00:15
01:00
00:15
---00:50
00:50
01:15
01:00
01:00
02:00
05:00
00:30
00:30
00:30
02:00
02:00
02:00
00:15
n/a
00:30
n/a
01:30
n/a
-mg/mL
00:15
n/a
00:15
n/a
00:15 mg/mL
01:00
n/a
01:00
n/a
01:30
n/a
n/a
n/a
n/a
-n/a
n/a
-n/a
n/a
n/a
n/a
n/a
n/a
0.2
n/a
n/a
2.5
n/a
n/a
n/a
n/a
n/a
n/a
2.1
n/a
n/a
15
n/a
n/a
n/a
800
n/a
n/a
n/a
--
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
--
--
0.01
0.12
n/a
n/a
--
n/a
n/a
2
n/a
n/a
4
--
--
600 mg / 300 mL (2 mg / mL)
X
--
00:45
--
02:00
01:00
8
1 gram / 100 mL (0.01 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
4 gram / 100 mL (0.04 gram / mL)
X
X
X
----
----
00:25
00:25
00:50
02:00
04:00
08:00
01:00
01:00
02:00
--- gram / --- mL
X
--
--
00:30
12:00
n/a
Hypersensitivity
--
--
X
X
mg
250
4000
--
500 mg / 50 mL (10 mg / mL)
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:25
00:25
00:25
01:00
01:00
01:00
n/a
n/a
n/a
gram/m
-L
00:30
n/a
00:30
n/a
00:30 mg/mL
X
X
mg
250
2000
--
--- mg / --- mL
X
--
00:15
--
01:00
00:30 mg/mL
--
2.5
40
--
X
X
mg
250
1000
--
250 mg / 50 mL (5 mg / mL)
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:25
00:25
00:50
02:00
02:00
02:00
00:30
n/a
00:30
n/a
01:00 mg/mL
n/a
n/a
--
n/a
n/a
2
n/a
n/a
5
--
X
X
mg
49
151
X
--
--
00:45
01:30
01:00 mg/mL
--
0.49
1.51
--
X
X
mg
300
500
400 mg / 250 mL (1.6 mg / mL)
X
--
--
00:30
02:00
01:00
n/a
n/a
n/a
--
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:30
01:30
00:30
01:00
n/a
n/a
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:25
01:30
n/a
n/a
gram/m
00:30
L
--
0.01
0.04
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
0.04
0.64
X
X
gram
0.5
7
meropenem
metroNIDAZOLE
300 --- mg / --- mL
--
nafcillin
X
ondansetron
Concentration Limits
Initial Conc. Hard
Soft
Soft
Value Units
Min
Min
Max
00:30
n/a
n/a
n/a
n/a
00:30
n/a
n/a
n/a
n/a
01:00
n/a
n/a
n/a
n/a
-mg/mL
-2
5
100 mg / 100 mL (1 mg / mL)
200 mg / 100 mL (2 mg / mL)
500
-300 mg / 250 mL (1.2 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1500 3000 1,000 mg / 100 mL (10 mg / mL)
--- mg / --- mL
250 mg / 50 mL (5 mg / mL)
750
-- 500 mg / 100 mL (5 mg / mL)
750 mg / 150 mL (5 mg / mL)
magnesium sulfate
moxifloxacin
S
-----
mg
levoFLOXacin
micafungin
P
X
X
X
X
Duration Limits
Soft
Soft
Min
Max
00:25 01:00
00:25 01:00
00:50 02:00
00:25 02:00
X
levETIRAcetam
methylPREDNISolone
Concentrations
250 mg / 100 mL (2.5 mg / mL)
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
Hard
Min
-----
X
iron sucrose
linezolid
Module
X
X
X
WVHN - 8/12/2011 08:17
gram
mg
0.2
2
2
32
--
--
Page 39 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
--
--
Intermittent Drugs - Med Surg
Available
As
Drug Name
Therapy
penG 2.5 Mill Units
penG 5 million units
Penicillin G
PENTobarbital
phenytoin
Loading Dose
phenytoin
Maintenance Dose
Pip/Tazo Extended
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
potassium chloride
Peripheral
potassium PHOSphate
Central
potassium PHOSphate
Peripheral
P
S
X
unit
2
3
--
2.5 unit / 100 mL (0.025 unit / mL)
X
--
--
00:25
01:00
00:30
n/a
n/a
n/a
n/a
1unit=1million
X
X
unit
4.5
5.5
--
5 unit / 250 mL (0.02 unit / mL)
X
--
--
00:25
02:00
00:30
n/a
n/a
n/a
n/a
1unit=1million
X
X
unit
1
5
--
--- unit / --- mL
X
--
--
00:25
01:00
00:30 unit/mL
0.02
--
0.05
1unit=1million
X
X
mg/kg
5
15
--
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
--
1
8
X
X
mg/kg
5
25
--
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
1
10
X
X
mg/kg
0.5
2.5
--
--- mg / --- mL
X
--
--
00:10
01:00
00:30 mg/mL
--
1
10
X
X
gram
3
4
--
3.37 gram / 50 mL (0.067 gram / mL)
X
--
--
03:45
04:30
04:00
n/a
n/a
n/a
n/a
2.25 gram / 50 mL (0.045 gram / mL)
3.37 gram / 50 mL (0.067 gram / mL)
4.5 gram / 100 mL (0.045 gram / mL)
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
X
X
X
------
---00:30
01:00
00:25
00:25
00:25
00:45
01:30
01:00
01:00
01:00
02:00
04:00
00:30
00:30
00:30
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
--- mEq / --- mL
X
--
00:50
01:00
04:00
--
0.1
--
0.4
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
---
00:45
01:30
---
03:00
06:00
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
--- mEq / --- mL
X
--
00:50
--
04:00
--
0.1
--
0.2
14 mmol / 250 mL (0.056 mmol / mL)
15 mmol / 100 mL (0.15 mmol / mL)
X
X
---
02:00
02:00
---
06:00
06:00
03:00
03:00
n/a
n/a
n/a
n/a
n/a
n/a
--- mmol / --- mL
X
--
03:00
--
09:00
04:00
--
0.01
0.24
14 mmol / 250 mL (0.056 mmol / mL)
X
--
02:00
--
06:00
03:00
--- mmol / --- mL
X
--
02:00
--
06:00
--
n/a
n/a
n/a
n/a
n/a
mEq/m
L
n/a
n/a
mEq/m
L
n/a
n/a
mmol/m
L
n/a
mmol/m
L
n/a
n/a
mg/mL
X
X
gram
0.75
4.5
--
X
X
mEq
5
60
--
X
X
X
X
mEq
mmol
5
14
40
40
--
--
tigeCYCLINE
Concentrations
X
X
mmol
10
30
--
X
X
mg
100
600
--
300 mg / 250 mL (1.2 mg / mL)
600 mg / 500 mL (1.2 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:50
00:50
00:55
03:00
03:00
03:00
01:00
01:00
--
X
X
mg/kg
1.5
6
--
--- mg / --- mL
X
--
00:45
--
02:00
01:00 mg/mL
15 mmol / 250 mL (0.06 mmol / mL)
X
--
02:00
--
06:00
03:00
X
X
mmol
10
60
--
--- mmol / --- mL
X
--
02:00
--
06:00
--
X
X
gram
2
3.1
--
3.1 gram / 100 mL (0.031 gram / mL)
X
--
--
00:25
01:00
X
X
mg
25
100
--
50 mg / 50 mL (1 mg / mL)
100 mg / 100 mL (1 mg / mL)
X
X
---
---
00:25
00:25
01:00
01:00
sodium phosphate
ticarcillin/clav
Clinical Ads.
Name
X
rifampin
SMX/TMP
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
piperacillin/tazo
potassium chloride
Central
Module
WVHN - 8/12/2011 08:17
Page 40 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Filter 0.22
Micron
Filter 0.22
Micron
Filter 0.22
Micron
---
--
--
--
n/a
n/a
n/a
--
0.01
0.07
n/a
n/a
--
n/a
n/a
0.1
n/a
n/a
6
--
--
0.1
1.2
48 Hour Tubing
--
n/a
mmol/m
L
n/a
n/a
n/a
--
0.03
0.3
00:30
n/a
n/a
n/a
n/a
--
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Dedicated IV
Line
--
Intermittent Drugs - Med Surg
Available
As
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Drug Name
Therapy
TOBRAmycin
valproate sodium
X
X
mg
40
600
--
X
X
mg
250
2000
--
Vanco Langlade
Concentration Limits
Initial Conc. Hard
Soft
Soft
Value Units
Min
Min
Max
00:30
n/a
n/a
n/a
n/a
00:30 mg/mL 0.5
-10
Concentrations
80 mg / 100 mL (0.8 mg / mL)
--- mg / --- mL
P
X
X
S
---
--- mg / --- mL
X
--
--
00:50
01:30
01:00 mg/mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 200 mL (5 mg / mL)
--- mg / --- mL
200 mg / 250 mL (0.8 mg / mL)
400 mg / 250 mL (1.6 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
X
X
X
X
X
X
-------------
-------01:00
-----
00:30
01:00
00:30
00:30
01:00
00:30
00:30
-00:30
00:50
01:45
01:45
01:30
02:30
03:30
01:30
02:30
03:30
01:30
02:30
03:30
02:00
04:00
04:00
01:00
01:30
-01:00
01:30
-01:00
01:30
-01:00
02:00
--
n/a
n/a
mg/mL
n/a
n/a
mg/mL
n/a
n/a
mg/mL
n/a
n/a
mg/mL
X
mg
210
2000
--
X
X
mg
210
2000
--
X
X
mg
210
2000
--
X
X
mg
50
600
--
X
X
mg/kg
1
2
--
--- mg / --- mL
X
--
--
00:50
01:30
01:00 mg/mL
X
X
mg
4
5
--
5 mg / 100 mL (0.05 mg / mL)
X
--
00:15
--
02:00
00:15
Vanco Wausau
VORIconazole
zoledronic (RECLAST)
Duration Limits
Soft
Soft
Min
Max
-01:00
-01:00
Hard
Min
00:25
00:25
X
Vanco Medford
zidovudine
Module
2.3.6 Fluids
Fluid Name
Therapy
..Maintenance IVF
.IVF + KCL 10 mEq/L
.IVF + KCL 20 mEq/L
.IVF + KCL 30 mEq/L
.IVF + KCL 40 mEq/L
.Maint IVF+Additives
Bicarb Drip
Blood (Cryoprecipit)
Blood (FFP)
Blood (platelets)
Blood (PRBCs)
Blood (whole)
Blood Reinfusion
Dextrose 10%
Hetastarch 6% NS
WVHN - 8/12/2011 08:17
Supports
Secondary
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
No
No
Yes
Yes
Fluids - Med Surg
Module
Rate Limits (mL/h)
P
S
Soft Soft Hard
Min
Max Max
X
-1
999
-X
-1
999
-X
-1
500
-X
-1
333
350
X
-1
250
275
X
-1
250
-X
-1
250
-X
X
10
300
-X
-20
150
-X
X
20
300
-X
-20
150
-X
-20
200
-X
-1
999
-X
-1
250
-X
-1
999
--
Clinical Ads. Name
--------Dedicated IV Line
-Dedicated IV Line
Dedicated IV Line
----
Page 41 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
Clinical Ads.
Name
--
--
0.1
11
n/a
n/a
-n/a
n/a
-n/a
n/a
-n/a
n/a
0.4
n/a
n/a
1
n/a
n/a
1
n/a
n/a
0.5
n/a
n/a
--
n/a
n/a
6
n/a
n/a
6
n/a
n/a
5
n/a
n/a
6
--
--
1
4
--
n/a
n/a
n/a
--
--
--
--
--
Fluid Name
Therapy
Lipids 20%
TPN
TPN - Cyclic
Supports
Secondary
No
No
No
Fluids - Med Surg
Module
Rate Limits (mL/h)
Clinical Ads. Name
P
S
Soft Soft Hard
Min
Max Max
X
-8
42
-- -X
-15
175
250 -X
-15
250
300 Central Line Only
2.3.7 PCA Drugs
Drug Name
Therapy
PCA Drugs - Med Surg
Concentrations:
600 mcg / 30 mL (20 mcg / mL)
fentaNYL
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
Drug Name
Therapy
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
10
10
10
10
5
40
50
50
50
50
15
60
Hard Min
n/a
Hard
Initial
Max
Value
150
400
150
200
n/a
--
10
-n/a
n/a
8
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mcg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
PCA Drugs - Med Surg
Concentrations:
6 mg / 30 mL (0.2 mg / mL)
HYDROmorphone
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
0.1
0.1
0.1
0.1
6
1
0.4
0.4
0.3
1
15
5
Hard Min
n/a
Hard
Initial
Max
Value
-1
--n/a
8
0.2
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 42 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
PCA Drugs - Med Surg
Concentrations:
300 mg / 30 mL (10 mg / mL)
meperidine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
Drug Name
Therapy
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
6
n/a
5
5
10
10
8
40
30
25
300
20
15
300
Hard Min
n/a
Hard
Initial
Max
Value
50
50
-50
n/a
--
10
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
PCA Drugs - Med Surg
Concentrations:
30 mg / 30 mL (1 mg / mL)
morphine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
5
n/a
0.1
0.5
0.5
0.5
6
2
4
6
8
8
30
50
Hard Min
n/a
Hard
Initial
Max
Value
8
10
10
10
n/a
--
1
1
n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 43 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
2.4 NICU
2.4.1 Continuous/Bolus - Non-Anesthesia Drugs
Drug Name
Therapy
Concentrations
Module
P
S
DOPamine
n/a
1,600 mcg / 1 mL (1,600 mcg / mL)
EPINEPHrine
--
10 mcg / 1 mL (10 mcg / mL)
esmolol
--
10 mg / 1 mL (10 mg / mL)
20 mg / 1 mL (20 mg / mL)
---
n/a
Continuous
mcg/kg/min
--
2 mg / 1 mL (2 mg / mL)
10 mg / 1 mL (10 mg / mL)
heparin
---
100 unit / 1 mL (100 unit / mL)
insulin
--
0.1 unit / 1 mL (0.1 unit / mL)
0.5 unit / 1 mL (0.5 unit / mL)
lidocaine
---
8 mg / 1 mL (8 mg / mL)
midazolam
--
0.1 mg / 1 mL (0.1 mg / mL)
0.5 mg / 1 mL (0.5 mg / mL)
1 mg / 1 mL (1 mg / mL)
2 mg / 1 mL (2 mg / mL)
-----
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
Clinical Ads.
Name
--
n/a
Continuous
mcg/kg/min
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
mcg/kg/h
0.05
1.5
--
--
--
--
--
--
--
--
--
--
--
25
1000
--
--
100
500
--
--
100
500
--
--
--
0.5
9
20
--
--
--
--
--
--
--
--
--
--
X
X
X
n/a
10 mcg / 1 mL (10 mcg / mL)
FUROSemide
Continuous/Bolus - Non-Anesthesia Drugs - NICU
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
1
20
40
----mcg/kg/min
X
fentaNYL
WVHN - 8/12/2011 08:17
Conc.
Limits
X
n/a
Continuous
mg/kg/h
0.05
0.4
1
--
--
--
--
--
--
--
--
--
Protect From
Light
n/a
Continuous
unit/kg/h
10
20
50
--
--
--
--
--
--
--
--
--
Heparin
n/a
Continuous
unit/kg/h
0.01
0.2
0.4
--
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mcg/kg/min
5
50
--
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mcg/kg/h
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
10
60
69
--
50
150
159
--
15
75
79
--
--
X
X
X
X
X
X
X
X
X
X
Page 44 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Module
Drug Name
Therapy
Concentrations
P
Conc.
Limits
S
milrinone
n/a
0.2 mg / 1 mL (0.2 mg / mL)
1 mg / 1 mL (1 mg / mL)
NORepinephrine
---
16 mcg / 1 mL (16 mcg / mL)
Sodium bicarb DRIP
--
0.5 mEq / 1 mL (0.5 mEq / mL)
1 mEq / 1 mL (1 mEq / mL)
vecuronium
---
1 mg / 1 mL (1 mg / mL)
2 mg / 1 mL (2 mg / mL)
---
Continuous/Bolus - Non-Anesthesia Drugs - NICU
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.2
1
3
----mcg/kg/min
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
Clinical Ads.
Name
--
X
X
n/a
Continuous
mcg/kg/min
0.01
2
6
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mEq/kg/h
0.2
2
--
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/kg/h
0.05
0.2
0.3
--
--
--
--
--
--
--
--
--
Neuromuscular
BA
X
X
X
X
X
2.4.2 Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits
No drugs exist in this section.
2.4.3 Continuous/Bolus - Anesthesia Only Drugs
No drugs exist in this section.
2.4.4 Continuous/Bolus - Anesthesia Only Drugs - Concentration Limits
No drugs exist in this section.
2.4.5 Intermittent Drugs
Intermittent Drugs - NICU
Available
As
Drug Name
Therapy
acyclovir
albumin 5%
amikacin
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Concentrations
P
S
Hard
Min
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
X
--
mg/kg
4
25
--
--- mg / --- mL
--
X
--
00:55
01:30
01:00 mg/mL
4.5
--
11
--
X
--
gram/kg
0.4
1.7
--
--- gram / --- mL
--
X
--
00:15
01:00
00:20
gram/m
L
0.4
--
0.55
--
X
--
mg/kg
4
22
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
4.5
--
5.5
--
WVHN - 8/12/2011 08:17
Page 45 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Intermittent Drugs - NICU
Available
As
Drug Name
Therapy
AMINOphylline
ampho B
(LIPOSOMAL)
azithromycin
caffeine citrate
Loading Dose
caffeine citrate
Maintenance Dose
calcium gluconate
ceFAZolin
cefoTAXime
cefOXitin
cefTAZidime
cefTRIAXone
ceFUROXime
CLINDAmycin
dexaMETHasone
DIGoxin
Loading Dose
DIGoxin
Maintenance Dose
erythromycin
fluCONazole
fosphenytoin
FUROsemide Bolus
gentamicin
hydroCORTisone
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
P
S
Hard
Min
X
--
mg/kg
0.6
9
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
4.5
--
5.5
--
X
--
mg/kg
4.5
7.5
--
--- mg / --- mL
--
X
--
01:55
02:10
02:00 mg/mL
--
1.5
2.5
--
X
--
mg/kg
5
12
--
--- mg / --- mL
--
X
--
00:50
01:30
01:00 mg/mL
1
--
3
--
X
--
mg/kg
19
41
--
--- mg / --- mL
--
X
--
00:10
01:00
00:30 mg/mL
9.5
--
11
--
X
--
mg/kg
4
10
20
--- mg / --- mL
--
X
--
00:10
01:30
mg/mL
9.5
--
11
--
X
--
mg/kg
42
230
250 --- mg / --- mL
--
X
00:10
00:15
01:50
01:00 mg/mL
49
--
51
Calcium
Precipitate
X
--
mg/kg
9
41
--
--- mg / --- mL
--
X
--
00:20
01:00
00:30 mg/mL
19
--
21
--
X
--
mg/kg
24
115
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
99
--
101
--
X
--
mg/kg
24
52
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
39
--
41
--
X
--
mg/kg
25
78
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
49
--
51
--
X
--
mg/kg
45
101
111 --- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
39
--
41
--
X
--
mg/kg
24
52
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
29
--
31
--
X
--
mg/kg
4
15
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
5
--
7
--
X
--
mg/kg
0.02
0.75
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
0.15
--
0.25
--
X
--
mcg/kg
15
52
--
--- mcg / --- mL
--
X
--
00:03
00:20
00:05 mcg/mL
9.5
--
11
--
X
--
mcg/kg
1
6
--
--- mcg / --- mL
--
X
--
00:03
01:00
mcg/mL
9.5
--
11
--
X
--
mg/kg
5
10
--
--- mg / --- mL
--
X
--
00:55
01:15
01:00 mg/mL
4.5
--
5.5
--
X
--
mg/kg
3
13
14
--- mg / --- mL
--
X
--
00:25
01:30
01:00 mg/mL
1.5
--
2.5
--
X
--
mg/kg
2
11.5
29
--- mg / --- mL
--
X
--
00:05
01:00
mg/mL
19
--
21
--
X
--
mg/kg
0.3
2
--
--- mg / --- mL
--
X
--
00:05
01:00
00:30 mg/mL
1.5
--
2.5
--
X
--
mg/kg
2
8
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
9.5
--
10.5
--
X
--
mg/kg
0.1
5
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
0.5
--
1.5
--
WVHN - 8/12/2011 08:17
Concentrations
Page 46 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
--
--
Intermittent Drugs - NICU
Available
As
Drug Name
Therapy
ibuprofen lysine
indomethacin
magnesium sulfate
meropenem
metoCLOPramide
metroNIDAZOLE
morphine BOLUS
nafcillin
PHENobarbital
Loading Dose
PHENobarbital
Maintenance Dose
phenytoin
piperacillin/tazo
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
P
S
Hard
Min
X
--
mg/kg
4.5
11
--
--- mg / --- mL
--
X
--
00:13
02:00
00:15 mg/mL
--
2.8
4
--
X
--
mg/kg
0.05
0.3
--
--- mg / --- mL
--
X
00:25
00:27
01:00
00:30 mg/mL
0.4
--
0.6
--
X
--
mg/kg
9
51
--
--- mg / --- mL
--
X
--
00:20
01:15
01:00 mg/mL
49
--
51
--
X
--
mg/kg
19
41
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
9.5
--
10.5
--
X
--
mg/kg
0.04
0.23
--
--- mg / --- mL
--
X
--
00:03
00:30
00:05 mg/mL
0.05
--
0.15
--
X
--
mg/kg
7
16
--
--- mg / --- mL
--
X
--
00:55
01:05
01:00 mg/mL
4.5
--
5.5
--
X
--
mg/kg
0.04
2.5
--
--- mg / --- mL
--
X
--
00:05
01:00
00:30 mg/mL
0.5
--
1.5
--
X
--
mg/kg
23
52
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
99
--
101
--
X
--
mg/kg
5
22
42
--- mg / --- mL
--
X
--
00:10
00:30
00:15 mg/mL
60
--
135
--
X
--
mg/kg
2
7
--
--- mg / --- mL
--
X
--
00:10
00:30
00:15 mg/mL
60
--
135
--
X
--
mg/kg
4
25
--
--- mg / --- mL
--
X
--
00:10
00:45
00:30 mg/mL
4.5
--
5.5
Filter 0.22
Micron
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
49
--
51
--
Concentrations
X
--
mg/kg
48
105
potassium
CHLOR_CENT
X
--
mEq/kg
0.2
1.5
2.5 --- mEq / --- mL
--
X
00:50
01:45
06:00
--
mEq/m
L
0.1
0.4
0.6
Central Line
Only
potassium
CHLOR_PERI
X
--
mEq/kg
0.2
1.5
2.5 --- mEq / --- mL
--
X
00:50
01:45
06:00
--
mEq/m
L
0.01
0.04
0.06
--
X
--
mmol/kg
0.04
0.4
0.6 --- mmol / --- mL
--
X
--
04:00
12:00
06:00
mmol/m
L
--
0.08
0.15
--
X
--
mg/kg
0.25
1.6
--
--- mg / --- mL
--
X
--
00:15
02:00
00:30 mg/mL
1.5
--
2.5
--
X
--
mg/kg
4
17
--
--- mg / --- mL
--
X
--
00:25
01:00
00:30 mg/mL
5
--
7
--
X
--
mg/kg
7
17
--
--- mg / --- mL
--
X
--
01:20
01:45
01:30 mg/mL
0.06
--
0.08
--
0.4
--
0.6
--
--
0.1
0.15
Calcium
Precipitate
4.5
--
5.5
--
potassium PHOSphate
ranitidine
rifampin
SMX/TMP
sodium bicarbonate
sodium phosphate
VANCOmycin
X
--
mEq/kg
0.8
3
X
--
mmol/kg
0.04
0.4
X
--
mg/kg
9
22
WVHN - 8/12/2011 08:17
--
--- mEq / --- mL
0.6 --- mmol / --- mL
--
--- mg / --- mL
Page 47 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
X
--
00:02
02:00
--
X
01:30
03:00
10:30
--
X
--
00:55
02:00
mEq/m
01:00
L
mmol/m
-L
01:00 mg/mL
Intermittent Drugs - NICU
Available
As
Drug Name
Therapy
zidovudine
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
--
mg/kg
0.8
2.3
--
Module
Concentrations
--- mg / --- mL
P
S
Hard
Min
--
X
00:40
2.4.6 Fluids
Fluid Name
Therapy
..Maintenance IVF
.Less than 1 kg
..Maintenance IVF
1 - 1.99 kg
..Maintenance IVF
2 - 2.99 kg
..Maintenance IVF
3 - 4 kg
..Maintenance IVF
Greater than 4 kg
Dextrose 10%
.Less than 1 kg
Dextrose 10%
1 - 1.99 kg
Dextrose 10%
2 - 2.99 kg
Dextrose 10%
3 - 4 kg
Dextrose 10%
Greater than 4 kg
Dextrose 12.5% IV
.Less than 1 kg
Dextrose 12.5% IV
1 - 1.99 kg
Dextrose 12.5% IV
2 - 2.99 kg
Dextrose 12.5% IV
3 - 4 kg
Dextrose 12.5% IV
Greater than 4 kg
Dextrose 15%
.Less than 1 kg
Dextrose 15%
1 - 1.99 kg
WVHN - 8/12/2011 08:17
Yes
Fluids - NICU
Module
Rate Limits (mL/h)
Clinical Ads. Name
P
S
Soft Soft Hard
Min
Max Max
X
X
0.1
6
11 --
Yes
X
X
0.1
12.5
20
--
Yes
X
X
0.1
19
31
--
Yes
X
X
0.1
25
42
--
Yes
X
X
0.1
50
83
--
Yes
X
X
0.1
6
11
--
Yes
X
X
0.1
12.5
20
--
Yes
X
X
0.1
19
31
--
Yes
X
X
0.1
25
42
--
Yes
X
X
0.5
50
83
--
Yes
X
X
0.1
6
11
--
Yes
X
X
0.1
12.5
20
--
Yes
X
X
0.1
19
31
--
Yes
X
X
0.1
25
42
--
Yes
X
X
0.1
50
83
--
No
X
X
0.1
6
11
--
No
X
X
0.1
12.5
20
--
Supports
Secondary
Page 48 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
00:50
03:00
--
mg/mL
--
3
5
Clinical Ads.
Name
--
Fluid Name
Therapy
Dextrose 15%
2 - 2.99 kg
Dextrose 15%
3 - 4 kg
Dextrose 15%
Greater than 4 kg
TPN
.Less than 1 kg
TPN
1 - 1.99 kg
TPN
2 - 2.99 kg
TPN
3 - 4 kg
TPN
Greater than 4 kg
Vanilla bag
.Less than 1 kg
Vanilla bag
1 - 1.99 kg
Vanilla bag
2 - 2.99 kg
Vanilla bag
3 - 4 kg
Vanilla bag
Greater than 4 kg
No
Fluids - NICU
Module
Rate Limits (mL/h)
Clinical Ads. Name
P
S
Soft Soft Hard
Min
Max Max
X
X
0.1
19
31 --
No
X
X
0.1
25
42
--
No
X
X
0.1
50
83
--
No
X
X
0.1
6
8
--
No
X
X
0.1
12.5
17
--
No
X
X
0.1
19
25
--
No
X
X
0.1
25
33
--
No
X
X
0.1
50
67
--
No
X
X
0.1
6
8
--
No
X
X
0.1
12.5
17
--
No
X
X
0.1
19
25
--
No
X
X
0.1
25
33
--
No
X
X
0.1
50
67
--
Supports
Secondary
2.4.7 PCA Drugs
No drugs exist in this section.
WVHN - 8/12/2011 08:17
Page 49 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
2.5 Oncology
2.5.1 Continuous/Bolus - Non-Anesthesia Drugs
Drug Name
Therapy
Concentrations
Module
P
S
AminocaproicINFUSION
n/a
5 gram / 250 mL (0.02 gram / mL)
AMINOphyllineINFUSIO
X
1,000 mg / 1,000 mL (1 mg / mL)
argatroban
.Standard Dosing
125 mg / 125 mL (1 mg / mL)
argatroban
Hepatic Dose
125 mg / 125 mL (1 mg / mL)
bivalirudin
.Standard Dosing
250 mg / 50 mL (5 mg / mL)
X
bivalirudin
Renal Dose
250 mg / 50 mL (5 mg / mL)
X
X
X
X
X
2,000 mcg / 100 mL (20 mcg / mL)
X
Clinical Ads.
Name
--
Continuous
mg/h
10
40
60
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mcg/kg/min
0.45
10
10.1
1.5
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mcg/kg/min
0.1
5
10.1
0.5
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mg/kg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Continuous
mg/kg/h
Bolus Dose
mg/kg
Bolus Admin Rate
mg/kg/min
Continuous
mg/h
0.095
1.8
--
1.75
0.3
0.76
--
0.75
0.3
0.76
--
0.75
--
0.24
1.1
--
1
0.3
0.76
--
0.75
0.3
0.76
--
0.75
--
0.1
4
8
--
--
--
--
--
--
--
--
--
--
Continuous
mcg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
10
100
--
--
25
100
--
--
12.5
50
--
--
--
--
--
--
--
--
n/a
25 mg / 100 mL (0.25 mg / mL)
50 mg / 200 mL (0.25 mg / mL)
fentaNYL
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
n/a
n/a
X
Continuous/Bolus - Non-Anesthesia Drugs - Oncology
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
1
2
5
1
---gram/h
--
bumetanide continuos
WVHN - 8/12/2011 08:17
Conc.
Limits
--n/a
--
Page 50 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Module
P
S
FUROSemide
1,000 mg / 100 mL (10 mg / mL)
--- mg / --- mL
heparin
X
X
--- unit / --- mL
insulin
Non-anesthesia
150 unit / 150 mL (1 unit / mL)
IVIG 10%
X
5 gram / 50 mL (0.1 gram / mL)
10 gram / 100 mL (0.1 gram / mL)
20 gram / 200 mL (0.1 gram / mL)
lepirudin
.Standard Dosing
100 mg / 250 mL (0.4 mg / mL)
lepirudin
Weight above 110kg
100 mg / 250 mL (0.4 mg / mL)
morphine
X
X
X
100 mg / 100 mL (1 mg / mL)
250 mg / 250 mL (1 mg / mL)
500 mg / 500 mL (1 mg / mL)
--- mg / --- mL
naloxone
X
X
X
X
0.8 mg / 250 mL (0.003 mg / mL)
4 mg / 1,000 mL (0.004 mg / mL)
--- mg / --- mL
octreotide
X
X
X
1,500 mcg / 500 mL (3 mcg / mL)
--- mcg / --- mL
X
X
X
X
X
X
--- mg / --- mL
X
WVHN - 8/12/2011 08:17
Initial
Value
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
-----
Clinical Ads.
Name
--
--YES Continuous
unit/h
200
2500
3500
--
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
unit/h
0.1
25
75
--
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/kg/h
25
250
480
50
--
--
--
--
--
--
--
--
--
n/a
Continuous
mg/kg/h
0.01
0.2
0.3
--
--
--
--
--
--
--
--
--
2nd RN to verify
n/a
Continuous
mg/h
16.4
16.6
16.7
16.5
--
--
--
--
--
--
--
--
2nd RN to verify
YES Continuous
mg/h
Bolus Dose
mg
Bolus Admin Rate
mg/min
YES Continuous
mg/h
0.5
25
--
--
0.5
10
--
--
0.25
2
--
--
--
0.064
3.9
--
--
--
--
--
--
--
--
--
--
--
YES Continuous
mcg/h
Bolus Dose
mcg
Bolus Admin Rate
mcg/min
n/a Continuous
mg/h
25
75
--
50
25
175
--
--
12
25
--
12.5
--
7
9
--
8
--
--
--
--
--
--
--
--
--
YES Continuous
mg/kg/h
0.5
1.5
--
1
--
--
--
--
--
--
--
--
--
--
--
----
--
--
-----
----
---
pantoprazole
80 mg / 100 mL (0.8 mg / mL)
Zidovudine infusion
Continuous/Bolus - Non-Anesthesia Drugs - Oncology
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
1
80
160
----mg/h
Conc.
Limits
--
--
Page 51 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
Concentrations
Conc.
Limits
Module
P
S
zz AMINODArone
n/a
150 mg / 100 mL (1.5 mg / mL)
zz DOBUTamine
X
500 mg / 250 mL (2 mg / mL)
zz DOPamine
X
400 mg / 250 mL (1.6 mg / mL)
zz EPINEPHrine
X
4 mg / 250 mL (0.016 mg / mL)
zz lidocaine
X
2 gram / 500 mL (0.004 gram / mL)
X
n/a
Continuous
mcg/kg/min
2.5
15
--
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mcg/kg/min
1
40
--
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mcg/kg/min
0.01
0.5
--
--
--
--
--
--
--
--
--
--
Code only drugs
n/a
Continuous
mg/min
Bolus Dose
mg/kg
Bolus Admin Rate
mg/min
Continuous
mcg/kg/min
0.5
5
--
--
0.5
3
--
1.5
10
50
--
--
Code only drugs
0.01
2
--
--
--
--
--
--
--
--
--
--
Code only drugs
0.02
9.5
--
--
--
--
--
--
--
--
--
--
Code only drugs
--
--
--
--
n/a
X
40 mg / 250 mL (0.16 mg / mL)
X
-n/a
Continuous
mcg/kg/min
--
2.5.2 Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Oncology
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
FUROSemide
X
-mg/mL
1
5
11
NonWeightBased
heparin
X
--
unit/mL
50
--
100
NonWeightBased
morphine
X
--
mg/mL
--
1
1.5
NonWeightBased
naloxone
X
--
mg/mL
--
0.001
0.006
NonWeightBased
WVHN - 8/12/2011 08:17
Initial
Value
--
Bolus Dose Administration
Rate
Clinical Ads.
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----Code only drugs
--
zz NORepinephrine
4 mg / 250 mL (0.016 mg / mL)
zz PHENYLephrine
Continuous/Bolus - Non-Anesthesia Drugs - Oncology
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
10
15
-----mg/min
Page 52 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Oncology
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
octreotide
X
-mcg/mL
-1
6
NonWeightBased
Zidovudine infusion
X
--
mg/mL
--
1
4
WeightBased
2.5.3 Continuous/Bolus - Anesthesia Only Drugs
Module
Drug Name
Therapy
Concentrations
P
Conc.
Limits
S
fentaNYL
n/a
50 mcg / 1 mL (50 mcg / mL)
--
insulin
Anesthesia only
150 unit / 150 mL (1 unit / mL)
X
n/a
X
Continuous/Bolus - Anesthesia Only Drugs - Oncology
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
1
6
--0.5
6
-mcg/kg/h
Bolus Dose
mcg/kg
Bolus Admin Rate
mcg/kg/min
Continuous
0.1
25
75
----unit/h
Initial
Value
--
--
Bolus Dose Administration
Rate
Soft
Soft
Hard Initial
Min
Max
Max Value
0.5
1
---
--
--
--
--
Clinical Ads.
Name
--
2nd RN to verify
--
2.5.4 Continuous/Bolus - Anesthesia Only Drugs - Concentration Limits
No drugs exist in this section.
2.5.5 Intermittent Drugs
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
Abraxane
acetaZOLAMIDE
acetylcysteine
First Dose
acetylcysteine
Second Dose
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
P
S
Hard
Min
X
X
mg/m2
80
260
--
--- mg / --- mL
X
--
--
00:20
01:00
00:30 mg/mL
--
5
5.1
--
X
X
mg
100
1000
--
--- mg / --- mL
X
--
--
00:15
01:00
00:30 mg/mL
--
10
100
--
X
X
mg/kg
140
160
--
--- mg / --- mL
X
--
--
00:30
02:00
01:00 mg/mL
1
--
75
--
X
X
mg/kg
40
60
--
--- mg / --- mL
X
--
--
03:30
05:00
04:00 mg/mL
1
--
75
--
WVHN - 8/12/2011 08:17
Concentrations
Page 53 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
acetylcysteine
Third Dose
acyclovir
albumin 25%
alemtuzumab
amifostine
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
amphotericin B
.Standard Dosing
amphotericin B
Blasto load < 100 KG
amphotericin B
Blasto load >= 100KG
amphotericin B
Blasto Maintenance
ampicillin
P
S
X
mg/kg
90
110
--
--- mg / --- mL
X
--
--
13:20
18:00
16:00 mg/mL
1
--
75
--
X
X
mg
100
2000
--
--- mg / --- mL
X
--
--
00:45
02:00
01:00 mg/mL
--
0.5
7
--
X
X
gram
12.5
25
--
12.5 gram / 50 mL (0.25 gram / mL)
25 gram / 100 mL (0.25 gram / mL)
X
X
---
---
00:15
00:20
01:00
01:00
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
--
X
X
mg
3
30
--
--- mg / --- mL
X
--
--
01:45
03:00
02:00 mg/mL
--
0.03
0.3
Protect From
Light
X
X
mg/m2
200
910
--
--- mg / --- mL
X
--
--
00:03
00:30
00:05 mg/mL
--
1
50
--
5 gram / 250 mL (0.02 gram / mL)
X
--
--
00:45
01:30
01:00
n/a
n/a
X
gram
4
5
--
--- gram / --- mL
X
--
--
00:45
01:30
n/a
gram/m
01:00
L
n/a
X
--
0.01
0.02
X
X
mg/kg
2.8
5.5
--
--- mg / --- mL
X
--
--
01:00
04:00
02:00 mg/mL
--
0.2
2
X
X
mg
1
100
--
--- mg / --- mL
X
--
00:59
--
06:00
--
0.05
0.25
X
X
mg/kg
0.45
0.55
0.6 --- mg / --- mL
X
--
--
02:30
03:30
03:00 mg/mL 0.009
0.09
0.25
X
X
mg
45
50
55
50 mg / 500 mL (0.1 mg / mL)
X
--
--
02:30
03:30
03:00
n/a
n/a
n/a
X
X
mg/kg
0.6
0.9
1
--- mg / --- mL
X
--
22:00
23:00
25:00
24:00 mg/mL
--
0.009
0.25
--
0.5 gram / 50 mL (0.01 gram / mL)
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
----
----
00:25
00:25
00:25
01:00
01:00
01:00
00:30
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1.5 gram / 50 mL (0.03 gram / mL)
3 gram / 100 mL (0.03 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
n/a
n/a
n/a
n/a
n/a
n/a
gram/m
0.005
L
n/a
n/a
n/a
n/a
gram/m
0.015
L
X
gram
0.2
3
ampicillin/sulbact
X
ATGAM-lymph horse lg
azactidine
azithromycin
aztreonam
Clinical Ads.
Name
X
X
arsenic trioxide
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
Aminocaproic LOAD
ampho B
(LIPOSOMAL)
Module
X
gram
0.1
3
4.5
Concentrations
--
n/a
n/a
mg/mL
n/a
--
0.1
n/a
n/a
n/a
n/a
--
0.45
--
-Protect From
Light
Protect From
Light
Protect From
Light
Protect From
Light
--
--
X
X
mg/kg
0.1
0.3
--
--- mg / --- mL
X
--
--
00:55
04:10
--
mg/mL
--
0.02
0.2
--
X
X
mg
2
45
--
--- mg / --- mL
X
--
01:45
03:30
12:00
--
mg/mL
--
0.9
4
--
X
X
mg/m2
37
100
--
--- mg / --- mL
X
--
00:05
--
00:40
00:10 mg/mL
--
0.5
2.5
--
X
X
mg
250
500
--
X
X
gram
0.25
2
--
500 mg / 250 mL (2 mg / mL)
--- mg / --- mL
1 gram / 100 mL (0.01 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
X
X
-----
00:50
00:50
---
--00:25
00:25
03:00
03:00
01:00
01:00
01:00
n/a
01:00 mg/mL
00:30
n/a
00:30
n/a
n/a
-n/a
n/a
n/a
0.5
n/a
n/a
n/a
2.5
n/a
n/a
WVHN - 8/12/2011 08:17
Page 54 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
---
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
bendamustine HCl
bevacizumab
First Dose
bevacizumab
Second Dose
bevacizumab
Subsequent Doses
bleomycin
calcium gluconate
CARBOplatin
carmustine
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
P
S
Hard
Min
--- gram / --- mL
X
--
--
Concentrations
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
gram/m
00:25 01:00 00:30
0.001
-0.2
L
X
X
mg/m2
50
120
--
--- mg / --- mL
X
--
--
00:30
01:00
X
X
mg/kg
5
15
--
--- mg / --- mL
X
--
01:15
--
X
X
mg/kg
5
15
--
--- mg / --- mL
X
--
00:45
X
X
mg/kg
5
15
--
--- mg / --- mL
X
--
00:20
X
X
unit/m2
9
30
--
--- unit / --- mL
X
--
X
X
---
--
--
0.1
0.6
--
03:00
01:30 mg/mL
--
1
25
--
--
01:30
01:00 mg/mL
--
1
25
--
--
01:30
00:30 mg/mL
--
1
25
--
00:10
--
01:30
01:00 unit/mL
--
0.1
3
--
00:10
00:10
00:45
00:45
06:00
06:00
01:00
n/a
01:00 mg/mL
n/a
--
n/a
10
n/a
200
--
--
0.6
3.6
---
X
X
mg
500
2000
--
X
X
mg
100
900
--
--- mg / --- mL
X
--
00:25
--
01:00
00:30 mg/mL
X
X
mg/m2
65
210
--
--- mg / --- mL
X
--
--
01:00
04:00
02:00 mg/mL
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:00
00:30
--- mg / --- mL
X
--
01:45
--
04:00
02:00 mg/mL
X
X
gram
0.25
2
--
cefePIME
X
X
gram
0.25
2
--
cefoTAXime
X
X
gram
0.25
2
--
cefOXitin
X
X
gram
0.5
2
--
cefTAZidime
X
X
gram
0.5
2
--
cefTRIAXone
X
X
X
X
WVHN - 8/12/2011 08:17
gram
mg/m2
0.125
350
2
450
--
--
Page 55 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Clinical Ads.
Name
mg/mL
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
ceFAZolin
cetuximab
Loading Dose
Module
n/a
n/a
gram/m
L
n/a
n/a
gram/m
L
n/a
n/a
gram/m
L
n/a
n/a
gram/m
L
n/a
n/a
gram/m
L
n/a
n/a
gram/m
L
--
0.1
0.3
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
--
1.5
3
--
--
--
--
--
-Filter 0.22
Micron
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
cetuximab
Maintenance Dose
chlorothiazide
CIPROfloxacin
CISplatin
cladribine
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
cytarabine INFUSION
cytarabine IVPB
dacarbazine
DAPTOmycin
Decitabine
denileukin
desmopressin
dexaMETHasone
dexRAZOXane < 2 m2
CrCl < 40 mL/min
dexRAZOXane < 2 m2
CrCl >= 40 mL/min
dexRAZOXane >= 2 m2
CrCl < 40 mL/min
dexRAZOXane >= 2 m2
CrCl >= 40 mL/min
diphenhydrAMINE
DOCEtaxel
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
P
S
Hard
Min
X
X
mg/m2
200
400
--
--- mg / --- mL
X
--
--
00:50
01:30
01:00 mg/mL
--
1.5
3
Filter 0.22
Micron
X
X
mg
250
2000
--
--- mg / --- mL
X
--
--
00:15
02:00
00:30 mg/mL
--
1
30
--
X
X
mg
200
400
--
200 mg / 100 mL (2 mg / mL)
400 mg / 200 mL (2 mg / mL)
X
X
---
---
00:50
00:50
02:00
02:00
01:00
01:00
n/a
n/a
n/a
n/a
n/a
n/a
--
X
X
mg/m2
18
105
--
--- mg / --- mL
X
--
--
00:30
06:00
01:00 mg/mL
--
0.04
0.5
--
X
X
mg/kg
0.08
0.1
--
--- mg / --- mL
X
--
21:00
23:00
25:00
24:00 mg/mL
--
0.01
0.056
--
X
X
X
X
-----
-----
00:10
00:20
00:20
00:10
01:00
01:00
01:00
01:00
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
n/a
n/a
n/a
--
n/a
n/a
n/a
3
n/a
n/a
n/a
18
--
CLINDAmycin
cycloPHOSPHAmide
Module
Concentrations
n/a
n/a
X
X
mg
50
900
--
300 mg / 50 mL (6 mg / mL)
600 mg / 50 mL (12 mg / mL)
900 mg / 50 mL (18 mg / mL)
--- mg / --- mL
X
X
mg/m2
200
2000
--
--- mg / --- mL
X
--
00:15
--
01:30
00:20 mg/mL
--
1
20
--
X
X
mg/m2
80
220
--
--- mg / --- mL
X
--
21:00
22:00
25:00
24:00 mg/mL
--
0.3
3
--
X
X
mg/m2
900
3300
--
--- mg / --- mL
X
--
--
01:45
04:00
02:00 mg/mL
--
0.9
7
--
X
X
mg/m2
150
1000
--
--- mg / --- mL
X
--
--
00:20
02:30
00:30 mg/mL
--
0.5
10
Protect From
Light
X
X
mg
250
500
--
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
---
---
00:25
00:25
01:00
01:00
00:30
n/a
00:30 mg/mL
n/a
2
n/a
--
n/a
15
--
X
X
mg/m2
8
20
--
--- mg / --- mL
X
--
00:50
--
03:20
mg/mL
--
0.05
0.2
--
X
X
mcg/kg
9
18
--
--- mcg / --- mL
X
--
--
00:30
01:30
01:00 mcg/mL
15
--
30
--
X
X
mcg/kg
0.25
0.35
--
--- mcg / --- mL
X
--
--
00:15
01:00
00:30 mcg/mL
--
0.01
4
--
X
X
mg
4
24
--
--- mg / --- mL
X
--
--
00:10
00:30
00:15 mg/mL
--
0.08
0.5
--
X
X
mg/m2
250
500
--
--- mg / --- mL
X
--
--
01:00
03:00
02:00 mg/mL
--
1
4
--
X
X
mg/m2
500
1000
--
--- mg / --- mL
X
--
--
01:00
03:00
02:00 mg/mL
--
1
4
--
X
X
mg
250
1000
--
--- mg / --- mL
X
--
--
01:00
03:00
02:00 mg/mL
--
1
4
--
X
X
mg
500
2000
--
--- mg / --- mL
X
--
--
01:00
03:00
02:00 mg/mL
--
1
4
--
X
X
mg
12.5
50
--
--- mg / --- mL
X
--
--
00:10
00:30
00:15 mg/mL
--
0.2
1
--
X
X
mg/m2
35
100
--
--- mg / --- mL
X
--
--
00:45
03:00
01:00 mg/mL
--
0.3
0.74
DEHP
WVHN - 8/12/2011 08:17
Page 56 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
dolasetron
DOXOrubicin
INFUSION
DOXOrubicin, liposo
doxyCYCLINE
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
etoposide
Etoposide CONT
INFUS
P
S
X
mg
12.5
100
--
--- mg / --- mL
X
--
--
00:10
00:30
00:15 mg/mL
--
0.2
2
--
X
X
mg/m2
8
17
--
--- mg / --- mL
X
--
21:00
22:00
25:00
24:00 mg/mL
--
0.03
0.2
Vesicant
X
X
mg/m2
20
50
--
--- mg / --- mL
X
--
--
00:30
02:00
--
0.12
0.44
Dextrose only
X
X
mg
25
200
--
100 mg / 250 mL (0.4 mg / mL)
--- mg / --- mL
1 gram / 50 mL (0.02 gram / mL)
X
X
X
----
----
00:45
00:45
00:25
04:00
04:00
02:00
n/a
-n/a
n/a
0.1
n/a
n/a
1
n/a
X
X
gram
0.45
1.25
--
--- gram / --- mL
X
--
--
00:25
02:00
--
0.01
0.02
X
X
mg
100
1000
--
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
---
---
00:30
00:30
02:00
02:00
01:00
n/a
01:00 mg/mL
00:30
n/a
gram/m
00:30
L
01:30
n/a
01:30 mg/mL
n/a
--
n/a
1
n/a
5
--
X
X
mg/m2
35
200
--
--- mg / --- mL
X
--
--
00:30
01:30
01:00 mg/mL
--
0.1
0.4
--
X
X
mg/m2
80
110
--
--- mg / --- mL
X
--
21:00
22:00
25:00
24:00 mg/mL
0.1
--
0.4
--
X
X
mg
62.5
500
--
X
X
mg
50
800
--
125 mg / 100 mL (1.25 mg / mL)
250 mg / 250 mL (1 mg / mL)
--- mg / --- mL
100 mg / 50 mL (2 mg / mL)
200 mg / 100 mL (2 mg / mL)
400 mg / 200 mL (2 mg / mL)
--- mg / --- mL
X
X
X
X
X
X
X
--------
--------
00:10
00:20
01:00
00:30
00:30
00:30
00:30
00:30
02:30
03:00
04:00
04:00
04:00
04:00
00:15
n/a
02:00
n/a
-mg/mL
01:00
n/a
01:00
n/a
02:00
n/a
-mg/mL
n/a
n/a
-n/a
n/a
n/a
--
n/a
n/a
1
n/a
n/a
n/a
1
n/a
n/a
5
n/a
n/a
n/a
2
X
X
mg/m2
10
30
--
--- mg / --- mL
X
--
--
00:15
01:15
01:00 mg/mL
--
0.2
1
--
X
X
mg/m2
200
2000
--
--- mg / --- mL
X
--
00:05
--
24:00
00:10 mg/mL
--
0.1
50
--
X
X
mg
115
150
--
150 mg / 250 mL (0.6 mg / mL)
X
--
00:16
--
00:40
00:20
n/a
n/a
n/a
--
X
X
mg
25
2000
X
X
mg
100
500
X
X
mg/kg
0.625
8
X
X
X
X
X
X
X
--------
--00:25
00:25
00:25
---
00:10
00:10
---00:50
00:50
00:30
00:30
00:45
00:45
00:45
02:00
02:00
00:20
n/a
00:20 mg/mL
00:30
n/a
00:30
n/a
00:30 mg/mL
01:00
n/a
01:00 mg/mL
n/a
-n/a
n/a
0.5
n/a
--
n/a
1.5
n/a
n/a
-n/a
1
n/a
25
n/a
n/a
7
n/a
10
X
X
mg/m2
500
1500
--
--- mg / --- mL
X
--
--
00:20
01:00
00:30 mg/mL
--
0.1
40
X
X
mg
40
800
--
X
X
mg
0.1
1.1
--
80 mg / 100 mL (0.8 mg / mL)
--- mg / --- mL
1 mg / 50 mL (0.02 mg / mL)
X
X
X
----
00:25
00:45
--
--00:10
01:20
01:20
00:30
01:00
n/a
01:00 mg/mL
00:15
n/a
n/a
0.5
n/a
n/a
-n/a
n/a
10
n/a
fluCONazole
fluoroURACIL
fosaprepitant_EMEND
fosphenytoin
furosemide in HSS
GANcyclovir
gemCITAbine
gentamicin
granisetron
Clinical Ads.
Name
X
ferric gluconate Na
fluDARAbine
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
ertapenem
erythromycin
Module
WVHN - 8/12/2011 08:17
Concentrations
100 mg / 50 mL (2 mg / mL)
--- mg / --- mL
250 mg / 150 mL (1.667 mg / mL)
1000 500 mg / 150 mL (3.333 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
---- mg / --- mL
--
Page 57 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
mg/mL
n/a
---
--
--
-------
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
IFOSfamide
IFOSfamide-MESNA
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
IPILIMumab
IRINOtecan
iron DEXTRAN
leucovorin
500
5000
--
--- mg / --- mL
X
--
00:30
--
24:00
X
X
mg/m2
1000 5500
--
--- mg / --- mL
X
--
02:00
--
X
X
mg
100
1000
--
250 mg / 100 mL (2.5 mg / mL)
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
X
X
X
X
-----
-----
X
X
unit/m2
10
22
--
--- unit / --- mL
X
--
X
X
mg/kg
2.8
3.2
--
--- mg / --- mL
X
X
X
mg/m2
60
350
--
--- mg / --- mL
X
X
mg
100
2000
--
linezolid
mg/mL
--
0.6
20
--
25:00
24:00 mg/mL
--
2
29
--
00:25
00:25
00:50
00:25
01:00
01:00
02:00
02:00
00:30
n/a
00:30
n/a
01:00
n/a
-mg/mL
n/a
n/a
n/a
--
n/a
n/a
n/a
2
n/a
n/a
n/a
5
--
00:15
--
60:00
00:20 unit/mL
--
0.2
0.6
1unit=1million
--
--
01:15
02:00
01:30 mg/mL
--
1
2
Filter 0.22
Micron
X
--
01:00
--
02:30
01:30 mg/mL
--
0.12
2.8
--
--- mg / --- mL
X
--
00:15
--
08:00
--
2
4
--
X
X
X
X
-----
-----
00:06
00:15
01:00
00:15
01:00
01:00
02:00
05:00
00:15
n/a
00:30
n/a
01:30
n/a
-mg/mL
n/a
n/a
n/a
--
n/a
n/a
n/a
0.2
n/a
n/a
n/a
2.1
Hypersensitivity
--
mg/mL
X
X
mg
25
500
--
X
X
mg/m2
15
40
--
--- mg / --- mL
X
--
02:40
--
03:20
03:00 mg/mL
--
0.2
0.6
DHEP and
Lactate
X
X
mg/m2
10
500
--
--- mg / --- mL
X
--
--
00:15
03:00
02:00 mg/mL
--
0.05
20
--
X
X
mg
250
X
X
mg
250
500 mg / 100 mL (5 mg / mL)
1500 3000 1,000 mg / 100 mL (10 mg / mL)
--- mg / --- mL
250 mg / 50 mL (5 mg / mL)
750
-- 500 mg / 100 mL (5 mg / mL)
750 mg / 150 mL (5 mg / mL)
X
X
X
X
X
X
--X
----
00:10
00:10
00:10
----
---00:50
00:50
01:15
00:30
00:30
00:30
02:00
02:00
02:00
00:15
n/a
00:15
n/a
00:15 mg/mL
01:00
n/a
01:00
n/a
01:30
n/a
n/a
n/a
-n/a
n/a
n/a
n/a
n/a
2.5
n/a
n/a
n/a
n/a
n/a
15
n/a
n/a
n/a
X
X
mg/m2
10
500
--
--- mg / --- mL
X
--
--
00:15
03:00
02:00 mg/mL
--
0.5
4.5
--
X
X
mg
5
500
--
--- mg / --- mL
X
--
00:30
00:45
02:00
01:00 mg/mL
0.5
--
5
--
X
X
mg
400
800
--
600 mg / 300 mL (2 mg / mL)
X
--
00:45
--
02:00
01:00
n/a
n/a
n/a
--
8
1 gram / 100 mL (0.01 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
4 gram / 100 mL (0.04 gram / mL)
X
X
X
----
----
00:25
00:25
00:50
02:00
04:00
08:00
01:00
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
--
--- gram / --- mL
X
--
--
00:30
12:00
--
0.01
0.12
12.5 gram / 50 mL (0.25 gram / mL)
25 gram / 100 mL (0.25 gram / mL)
X
X
---
00:05
00:10
---
00:10
00:20
n/a
n/a
n/a
n/a
n/a
n/a
magnesium sulfate
X
mannitol 25%
--
Clinical Ads.
Name
100 mg / 100 mL (1 mg / mL)
200 mg / 100 mL (2 mg / mL)
300 mg / 250 mL (1.2 mg / mL)
--- mg / --- mL
levoFLOXacin
levoLEUCOvorin
S
--
mg/m2
levETIRAcetam
levoLEUCOvorin
P
X
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
00:10 00:30 00:15 mg/mL
-0.002
0.2
X
iron sucrose
ixabepilone
Concentrations
--- mg / --- mL
Hard
Min
--
X
imipenem/cilastatin
interferon alpha-2b
Module
X
X
X
WVHN - 8/12/2011 08:17
gram
gram
0.5
12.5
7
25
--
Page 58 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
n/a
n/a
n/a
gram/m
-L
00:05
n/a
00:10
n/a
--
--
--
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
meropenem
MESNA BOLUS
MESNA INFUSION
methoTREXATE
.Standard Dosing
methoTREXATE
High Dose - GRAMS
methylPREDNISolone
mitoMYcin
mitoXANtrone
PACLitaxel 3 weeks
PACLitaxel weekly
Palonosetron
--
250
4000
--
500 mg / 50 mL (10 mg / mL)
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
X
X
X
----
X
X
mg/m2
200
600
--
--- mg / --- mL
X
--
--
00:10
00:30
00:15 mg/mL
--
4
30
--
X
X
mg/m2
600
2500
--
--- mg / --- mL
X
--
21:00
22:00
25:00
24:00 mg/mL
--
3
11
--
X
X
mg/m2
20
50
--
--- mg / --- mL
X
--
--
00:15
12:00
--
--
mg/mL
--
0.1
25
--
--
gram/m
L
--
0.01
0.25
--
X
X
gram/m2
1
12
--
--- gram / --- mL
X
--
--
01:00
25:00
X
X
mg
250
2000
--
--- mg / --- mL
X
--
00:15
--
01:00
00:30 mg/mL
--
2.5
40
--
X
X
mg
250
1000
--
250 mg / 50 mL (5 mg / mL)
500 mg / 100 mL (5 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:25
00:25
00:50
02:00
02:00
02:00
00:30
n/a
00:30
n/a
01:00 mg/mL
n/a
n/a
--
n/a
n/a
2
n/a
n/a
5
--
X
X
mg
49
151
X
--
--
00:45
01:30
01:00 mg/mL
--
0.49
1.51
--
X
X
mg/m2
10
20
--
--- mg / --- mL
X
--
--
00:15
00:30
00:20 mg/mL
--
0.4
2
Vesicant
X
X
mg/m2
10
15
--
--- mg / --- mL
X
--
--
00:20
00:45
00:30 mg/mL
Vesicant
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:25
00:25
01:30
01:30
00:30
01:00
--- gram / --- mL
X
--
--
00:25
01:30
300 --- mg / --- mL
--
0.2
0.4
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
n/a
--
n/a
0.04
n/a
0.64
--
X
X
mg
2
32
--
32 mg / 50 mL (0.64 mg / mL)
--- mg / --- mL
X
X
---
---
00:20
00:10
01:00
01:00
n/a
n/a
gram/m
00:30
L
00:30
n/a
00:15 mg/mL
X
X
mg/m2
75
135
--
--- mg / --- mL
X
--
--
01:45
03:00
02:00 mg/mL
--
0.3
1.5
Dextrose only
X
X
mg/m2
120
230
--
--- mg / --- mL
X
--
--
02:30
05:00
03:00 mg/mL
--
0.3
1.2
Non-PVC
X
X
mg/m2
25
100
--
--- mg / --- mL
X
--
--
00:45
02:00
01:00 mg/mL
--
0.3
1.2
--
X
X
mg
0.2
0.25
--
0.25 mg / 50 mL (0.005 mg / mL)
X
--
--
00:10
00:30
00:15
n/a
n/a
n/a
--
X
X
X
X
-----
01:00
01:00
---
01:45
01:45
02:00
02:00
06:00
06:00
06:00
06:00
02:00
n/a
02:00
n/a
04:00
n/a
04:00 mg/mL
n/a
n/a
n/a
--
n/a
n/a
n/a
0.001
n/a
n/a
n/a
0.4
Dedicated IV
Line
X
--
--
00:50
01:30
01:00 mg/mL
--
5
10
--
X
gram
0.2
2
--
pamidronate
panitumumab
S
X
mg
X
OXALiplatin
Concentrations
Clinical Ads.
Name
X
nafcillin
ondansetron
P
--- gram / --- mL
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
gram/m
00:05
-00:20 00:10
-0.1
0.25
L
-00:25 01:00 00:30
n/a
n/a
n/a
n/a
-00:25 01:00 00:30
n/a
n/a
n/a
n/a
-00:25 01:00 00:30 mg/mL
-2
4
Hard
Min
X
metroNIDAZOLE
micafungin
Module
X
X
mg
29
90
--
30 mg / 250 mL (0.12 mg / mL)
60 mg / 250 mL (0.24 mg / mL)
90 mg / 250 mL (0.36 mg / mL)
--- mg / --- mL
X
X
mg/kg
3
6
--
--- mg / --- mL
WVHN - 8/12/2011 08:17
Page 59 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
--
Intermittent Drugs - Oncology
Available
As
Drug Name
Therapy
PEMEtrexed
penG 2.5 Mill Units
penG 5 million units
Penicillin G
pentoSTATIN
Pip/Tazo Extended
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
potassium chloride
Peripheral
potassium PHOSphate
Central
potassium PHOSphate
Peripheral
prochlorperazine
P
S
X
X
mg/m2
375
500
--
--- mg / --- mL
X
--
00:08
--
00:15
00:10 mg/mL
X
X
unit
2
3
--
2.5 unit / 100 mL (0.025 unit / mL)
X
--
--
00:25
01:00
00:30
X
X
unit
4.5
5.5
--
5 unit / 250 mL (0.02 unit / mL)
X
--
--
00:25
02:00
00:30
X
X
unit
1
5
--
--- unit / --- mL
X
--
--
00:25
01:00
X
X
mg/m2
4
6
--
--- mg / --- mL
X
--
--
00:25
X
X
gram
3
4
--
3.37 gram / 50 mL (0.067 gram / mL)
X
--
--
2.25 gram / 50 mL (0.045 gram / mL)
3.37 gram / 50 mL (0.067 gram / mL)
4.5 gram / 100 mL (0.045 gram / mL)
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
X
X
X
------
---00:30
01:00
--- mEq / --- mL
X
--
10 mEq / 100 mL (0.1 mEq / mL)
20 mEq / 100 mL (0.2 mEq / mL)
X
X
--- mEq / --- mL
X
X
gram
0.75
4.5
--
X
X
mEq
5
60
--
X
X
X
X
mEq
mmol
5
14
40
40
--
--
SMX/TMP
--
3
13
--
n/a
n/a
n/a
n/a
1unit=1million
n/a
n/a
n/a
n/a
1unit=1million
00:30 unit/mL
0.02
--
0.05
1unit=1million
01:00
00:30 mg/mL
--
0.02
0.06
--
03:45
04:30
04:00
n/a
n/a
n/a
n/a
--
00:25
00:25
00:25
00:45
01:30
01:00
01:00
01:00
02:00
04:00
00:30
00:30
00:30
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
00:50
01:00
04:00
--
0.1
--
0.4
---
00:45
01:30
---
03:00
06:00
01:00
02:00
n/a
n/a
n/a
n/a
n/a
n/a
X
--
00:50
--
04:00
--
0.1
--
0.2
14 mmol / 250 mL (0.056 mmol / mL)
15 mmol / 100 mL (0.15 mmol / mL)
X
X
---
02:00
02:00
---
06:00
06:00
03:00
03:00
n/a
n/a
n/a
n/a
n/a
n/a
--- mmol / --- mL
X
--
03:00
--
09:00
04:00
--
0.01
0.24
14 mmol / 250 mL (0.056 mmol / mL)
X
--
02:00
--
06:00
03:00
n/a
n/a
n/a
--- mmol / --- mL
X
--
02:00
--
06:00
--
n/a
n/a
n/a
n/a
n/a
mEq/m
L
n/a
n/a
mEq/m
L
n/a
n/a
mmol/m
L
n/a
mmol/m
L
--
0.01
0.07
--
--
--
--
X
mmol
10
30
--
X
X
mg
5
10
--
--- mg / --- mL
X
--
--
00:10
00:30
00:15 mg/mL
--
0.1
0.2
--
X
X
mg
100
600
--
300 mg / 250 mL (1.2 mg / mL)
600 mg / 500 mL (1.2 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:50
00:50
00:55
03:00
03:00
03:00
01:00
n/a
01:00
n/a
-mg/mL
n/a
n/a
--
n/a
n/a
0.1
n/a
n/a
6
--
X
X
mg/m2
60
500
--
--- mg / --- mL
X
--
--
01:00
25:00
mg/mL
--
0.4
4
Hypersensitivity
X
X
mg/kg
1.5
6
--
--- mg / --- mL
X
--
00:45
--
02:00
01:00 mg/mL
--
0.1
1.2
48 Hour Tubing
15 mmol / 250 mL (0.06 mmol / mL)
X
--
02:00
--
06:00
03:00
n/a
n/a
n/a
X
X
mmol
10
60
--
--- mmol / --- mL
X
--
02:00
--
06:00
--
--
0.03
0.3
X
X
mg/m2
400
500
--
--- mg / --- mL
X
--
--
00:45
02:00
--
0.8
2.5
sodium phosphate
STREPTOzocin
Concentrations
Clinical Ads.
Name
X
rifampin
riTUXimab
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
piperacillin/tazo
potassium chloride
Central
Module
WVHN - 8/12/2011 08:17
Page 60 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
n/a
mmol/m
L
01:00 mg/mL
--
---
Intermittent Drugs - Oncology
Available
As
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Drug Name
Therapy
temSIROlimus
ticarcillin/clav
tigeCYCLINE
TOBRAmycin
topoTECAN
trastuzumab
Loading Dose
trastuzumab
Subsequent Doses
valproate sodium
P
S
X
X
mg
15
25
--
--- mg / --- mL
X
--
00:25
--
01:15
00:30 mg/mL
X
X
gram
2
3.1
--
3.1 gram / 100 mL (0.031 gram / mL)
X
--
--
00:25
01:00
00:30
X
X
mg
25
100
--
X
X
mg
40
600
--
50 mg / 50 mL (1 mg / mL)
100 mg / 100 mL (1 mg / mL)
80 mg / 100 mL (0.8 mg / mL)
--- mg / --- mL
X
X
X
X
-----
--00:25
00:25
00:25
00:25
---
01:00
01:00
01:00
01:00
X
X
mg/m2
0.4
4.2
--
--- mg / --- mL
X
--
--
00:20
X
X
mg/kg
4
8
--
--- mg / --- mL
X
--
--
X
X
mg/kg
2
6
--
--- mg / --- mL
X
--
X
X
mg
250
2000
--
--- mg / --- mL
X
X
X
mg
100
2000
--
X
X
mg
100
2000
--
X
X
mg
250
2000
--
X
X
mg
50
600
--
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
500 mg / 100 mL (5 mg / mL)
1,000 mg / 200 mL (5 mg / mL)
--- mg / --- mL
200 mg / 250 mL (0.8 mg / mL)
400 mg / 250 mL (1.6 mg / mL)
--- mg / --- mL
X
X
mg/kg
1
2
--
X
X
mg
4
5
X
X
mg
2
4
0.099
0.1
Non-PVC
n/a
n/a
n/a
--
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
n/a
n/a
n/a
0.5
n/a
n/a
n/a
--
n/a
n/a
n/a
10
Dedicated IV
Line
01:00
00:30 mg/mL
--
0.01
0.1
--
01:20
02:00
01:30 mg/mL
--
0.4
5
--
--
00:25
02:00
00:30 mg/mL
--
0.4
5
--
--
--
00:50
01:30
01:00 mg/mL
--
0.1
11
--
X
X
X
X
X
X
X
X
X
X
X
X
-------------
-------01:00
-----
00:30
01:00
00:30
00:30
01:00
00:30
00:30
-00:30
00:50
01:45
01:45
01:30
02:30
03:30
01:30
02:30
03:30
01:30
02:30
03:30
02:00
04:00
04:00
01:00
01:30
-01:00
01:30
-01:00
01:30
-01:00
02:00
--
n/a
n/a
-n/a
n/a
-n/a
n/a
-n/a
n/a
0.4
n/a
n/a
1
n/a
n/a
1
n/a
n/a
0.5
n/a
n/a
--
n/a
n/a
6
n/a
n/a
6
n/a
n/a
5
n/a
n/a
6
--- mg / --- mL
X
--
--
00:50
01:30
01:00 mg/mL
--
1
4
--
--
5 mg / 100 mL (0.05 mg / mL)
X
--
00:15
--
02:00
00:15
n/a
n/a
n/a
--
--
4 mg / 100 mL (0.04 mg / mL)
--- mg / --- mL
X
X
---
00:15
00:15
---
02:00
02:00
00:15
n/a
00:15 mg/mL
n/a
--
n/a
0.03
n/a
0.04
--
Vanco Wausau
VORIconazole
zoledronic (ZOMETA)
Concentrations
2.5.6 Fluids
Fluid Name
Therapy
..Maintenance IVF
WVHN - 8/12/2011 08:17
Supports
Secondary
Yes
Clinical Ads.
Name
--
Vanco Medford
zoledronic (RECLAST)
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Hard
Min
Vanco Langlade
zidovudine
Module
Fluids - Oncology
Module
Rate Limits (mL/h)
Clinical Ads. Name
P
S
Soft Soft Hard
Min
Max Max
X
-1
999
-- --
Page 61 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
n/a
n/a
mg/mL
n/a
n/a
mg/mL
n/a
n/a
mg/mL
n/a
n/a
mg/mL
n/a
--
--
--
--
--
Fluid Name
Therapy
.IVF + KCL 10 mEq/L
.IVF + KCL 20 mEq/L
.IVF + KCL 30 mEq/L
.IVF + KCL 40 mEq/L
.Maint IVF+Additives
Bicarb Drip
Blood (Cryoprecipit)
Blood (FFP)
Blood (platelets)
Blood (PRBCs)
Blood (whole)
Blood Reinfusion
Dextrose 10%
Lipids 20%
Sodium Chlor 3%
TPN
TPN - Cyclic
Supports
Secondary
Yes
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
No
No
Yes
No
Yes
No
No
Fluids - Oncology
Module
Rate Limits (mL/h)
P
S
Soft Soft Hard
Min
Max Max
X
-1
999
-X
-1
999
-X
-1
333
350
X
-1
250
275
X
-1
250
-X
-1
250
-X
X
10
300
-X
-20
150
-X
X
20
300
-X
-20
150
-X
-20
200
-X
-1
999
-X
-1
250
-X
-8
42
-X
-1
50
100
X
-15
175
250
X
-15
250
300
Clinical Ads. Name
-------Dedicated IV Line
Dedicated IV Line
Dedicated IV Line
Dedicated IV Line
-----Central Line Only
2.5.7 PCA Drugs
Drug Name
Therapy
PCA Drugs - Oncology
Concentrations:
600 mcg / 30 mL (20 mcg / mL)
fentaNYL
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
10
10
10
10
5
40
50
50
50
50
15
60
Hard Min
n/a
Hard
Initial
Max
Value
150
400
150
200
n/a
--
10
-n/a
n/a
8
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mcg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 62 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
PCA Drugs - Oncology
Concentrations:
6 mg / 30 mL (0.2 mg / mL)
HYDROmorphone
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
Drug Name
Therapy
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
-n/a
0.1
0.1
0.1
0.1
6
1
0.4
0.4
0.3
1
15
5
Hard Min
n/a
Hard
Initial
Max
Value
-1
--n/a
8
0.2
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
PCA Drugs - Oncology
Concentrations:
300 mg / 30 mL (10 mg / mL)
meperidine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
6
n/a
5
5
10
10
8
40
30
25
300
20
15
300
Hard Min
n/a
Hard
Initial
Max
Value
50
50
-50
n/a
--
10
-n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 63 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Drug Name
Therapy
PCA Drugs - Oncology
Concentrations:
30 mg / 30 mL (1 mg / mL)
morphine
Concentration Limits
Limits
PCA Dose
Continuous Dose / h
Bolus Dose
Loading Dose
Lockout Interval (minutes)
Max Acc. Dose Range / 4 h
WVHN - 8/12/2011 08:17
Conc. Units
n/a
Hard Soft
Soft
Min
Min
Max
n/a
n/a
n/a
n/a
5
n/a
0.1
0.5
0.5
0.5
6
2
4
6
8
8
30
50
Hard Min
n/a
Hard
Initial
Max
Value
8
10
10
10
n/a
--
1
1
n/a
n/a
10
--
Soft Min
n/a
PCA Pause Protocol:
Yes
Soft Max
n/a
Dosing Units
mg
Max Accum. Includes Bolus?
Yes
Clinical Advisory Name
2nd RN to verify
Page 64 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
2.6 Pediatrics
2.6.1 Continuous/Bolus - Non-Anesthesia Drugs
Drug Name
Therapy
Concentrations
Continuous/Bolus - Non-Anesthesia Drugs - Pediatrics
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
YES Continuous
200
2500
3500
----unit/h
Conc.
Limits
Module
P
S
--- unit / --- mL
insulin
Non-anesthesia
150 unit / 150 mL (1 unit / mL)
--- unit / --- mL
IVIG 10%
X
--
5 gram / 50 mL (0.1 gram / mL)
10 gram / 100 mL (0.1 gram / mL)
20 gram / 200 mL (0.1 gram / mL)
X
X
X
heparin
X
X
YES Continuous
unit/h
0.1
25
75
--
--
--
--
--
--
--
--
--
2nd RN to verify
Continuous
mg/kg/h
25
250
480
50
--
--
--
--
--
--
--
--
--
--n/a
----
2.6.2 Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits
Continuous/Bolus - Non-Anesthesia Drugs - Concentration Limits - Pediatrics
Module
Concentration Limits
Drug Name
Therapy
P
S
Conc.
Hard
Soft
Soft
Dosing Method
Units
Min
Min
Max
heparin
X
-unit/mL
50
-100
NonWeightBased
insulin
Non-anesthesia
NonWeightBased
WVHN - 8/12/2011 08:17
X
Initial
Value
--
Bolus Dose Administration
Rate
Clinical Ads.
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----2nd RN to verify
--
unit/mL
--
0.2
1.5
Page 65 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
2.6.3 Continuous/Bolus - Anesthesia Only Drugs
Module
Drug Name
Therapy
Concentrations
P
insulin
Anesthesia only
150 unit / 150 mL (1 unit / mL)
Conc.
Limits
S
n/a
X
Continuous/Bolus - Anesthesia Only Drugs - Pediatrics
Dosing
Continuous
Bolus
Units
Soft
Soft
Hard Initial Soft
Soft
Hard
Min
Max
Max Value
Min
Max
Max
Continuous
0.1
25
75
----unit/h
Initial
Value
--
Bolus Dose Administration
Clinical Ads.
Rate
Name
Soft
Soft
Hard Initial
Min
Max
Max Value
----2nd RN to verify
--
2.6.4 Continuous/Bolus - Anesthesia Only Drugs - Concentration Limits
No drugs exist in this section.
2.6.5 Intermittent Drugs
Intermittent Drugs - Pediatrics
Available
As
Drug Name
Therapy
acetaZOLAMIDE
pt weight < 40kg
acetaZOLAMIDE
pt weight >= 40kg
acetylcysteine
acyclovir
albumin 25%
pt weight < 40kg
albumin 25%
pt weight >= 40kg
albumin 5%
amikacin
AMINOphylline
ampho B
(LIPOSOMAL)
ampicillin
pt weight < 40kg
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
P
S
--- mg / --- mL
X
--
--
00:10
01:00
--
mg/mL
--
95
105
--
330 --- mg / --- mL
X
--
--
00:10
01:00
--
mg/mL
--
95
105
--
--
mg/mL
--
1
45
--
4.5
--
11
--
--
0.24
0.26
--
n/a
n/a
n/a
n/a
n/a
n/a
--
0.24
0.26
--
0.04
0.06
--
X
mg/kg
4
6
X
X
mg
150
250
X
X
mg/kg
40
160
--
--- mg / --- mL
X
X
00:10
00:50
17:00
X
X
mg/kg
4
25
--
--- mg / --- mL
X
--
00:40
00:50
03:00
X
X
X
gram/kg
gram
0.75
12.5
1.5
50
--
Concentrations
X
X
Clinical Ads.
Name
Hard
Min
2
--
01:00 mg/mL
--- gram / --- mL
X
X
00:40
00:50
06:00
--
12.5 gram / 50 mL (0.25 gram / mL)
25 gram / 100 mL (0.25 gram / mL)
X
X
X
X
00:40
00:40
00:50
00:50
06:00
06:00
---
--- gram / --- mL
X
X
00:40
00:50
06:00
---
gram/m
L
n/a
n/a
gram/m
L
gram/m
L
--
X
X
gram/kg
0.1
1.7
--
--- gram / --- mL
X
X
--
00:50
06:00
X
X
mg/kg
4
22
35
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
--
4
11
--
X
X
mg/kg
0.6
9
--
--- mg / --- mL
X
--
00:02
00:10
01:30
00:30 mg/mL
--
4.5
5.5
--
X
X
mg/kg
2.6
11.5
--
--- mg / --- mL
X
--
00:40
00:50
05:00
02:00 mg/mL
--
1.5
2.5
--
X
X
mg/kg
20
52.5
60
--- mg / --- mL
X
--
00:03
00:08
01:30
00:30 mg/mL
--
5
25
--
WVHN - 8/12/2011 08:17
Page 66 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Intermittent Drugs - Pediatrics
Available
As
Drug Name
Therapy
ampicillin
pt weight >= 40kg
ampicillin/sulbact
pt weight < 40kg
ampicillin/sulbact
pt weight >= 40kg
azithromycin
pt weight < 50kg
azithromycin
pt weight >= 50kg
aztreonam
pt weight < 60kg
aztreonam
pt weight >= 60kg
caffeine citrate
calcium gluconate
pt weight < 40kg
calcium gluconate
pt weight >= 40kg
caspoFUNGIN
pt weight < 60kg
caspoFUNGIN
pt weight >= 60kg
ceFAZolin
pt weight < 60kg
ceFAZolin
pt weight >= 60kg
cefePIME
pt weight < 40kg
cefePIME
pt weight >= 40kg
cefoTAXime
pt weight < 30kg
cefoTAXime
pt weight >= 30kg
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Concentrations
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
gram/m
00:03 00:08 01:30 00:30
-0.005
0.02
L
Hard
Min
P
S
X
X
gram
0.25
3
--
--- gram / --- mL
X
--
X
X
mg/kg
40
67.75
70
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
1.5 gram / 50 mL (0.03 gram / mL)
X
--
--
00:25
01:00
00:30
X
X
gram
0.25
3
--
--- gram / --- mL
X
--
--
00:25
01:00
X
X
mg/kg
5
12
--
--- mg / --- mL
X
--
01:00
01:30
03:00
X
X
---
00:45
00:45
---
02:00
02:00
25
35
n/a
n/a
n/a
--
0.005
0.06
02:00 mg/mL
--
0.9
2.2
--
01:00
n/a
01:00 mg/mL
n/a
--
n/a
0.5
n/a
2.5
---
n/a
gram/m
00:30
L
X
X
mg
250
500
--
X
X
mg/kg
25
35
37
--- mg / --- mL
X
X
00:10
00:15
02:00
00:30 mg/mL
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
00:10
00:10
00:15
00:15
02:00
02:00
00:30
00:30
--- gram / --- mL
X
--
00:10
00:15
02:00
--- mg / --- mL
X
X
00:03
00:08
02:00
X
gram
0.4
2
--
--
--
5
30
n/a
n/a
n/a
n/a
n/a
n/a
--
0.01
0.04
mg/mL
--
5
22
--
n/a
n/a
gram/m
00:30
L
--
X
mg/kg
3
41
X
X
mg
100
500
1000 --- mg / --- mL
X
--
00:15
--
01:30
01:00 mg/mL
--
4
20
--
X
X
mg
500
2000 3000 --- mg / --- mL
X
X
00:15
--
06:00
01:00 mg/mL
--
10
51
--
X
X
mg/kg
1
2
--
--- mg / --- mL
X
X
00:40
00:50
03:00
--
mg/mL
--
0.05
0.55
--
X
X
mg
50
90
--
--- mg / --- mL
X
X
00:40
00:50
03:00
--
mg/mL
--
0.05
0.55
--
X
X
mg/kg
9
33
--
--- mg / --- mL
X
X
--
00:20
01:00
00:30 mg/mL
--
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:20
00:20
01:00
01:00
00:30
00:30
--- gram / --- mL
X
--
--
00:20
01:00
--- mg / --- mL
X
X
--
00:20
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
--- gram / --- mL
X
--
X
X
X
X
X
gram
mg/kg
gram
0.25
38
0.25
2
52.5
2
--
60
--
--
--
X
X
--
--
--
500 mg / 250 mL (2 mg / mL)
--- mg / --- mL
X
Clinical Ads.
Name
--
10
30
n/a
n/a
gram/m
00:30
L
n/a
n/a
n/a
n/a
n/a
n/a
--
0.005
0.04
02:00
00:30 mg/mL
--
10
100
00:20
00:20
02:00
02:00
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
--
00:20
02:00
n/a
n/a
gram/m
00:30
L
--
0.005
0.1
--
10
50
--
n/a
n/a
n/a
n/a
n/a
n/a
--
X
X
mg/kg
25
70
75
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
X
X
gram
0.5
2
--
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:20
00:20
01:00
01:00
00:30
00:30
WVHN - 8/12/2011 08:17
Page 67 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
n/a
n/a
--
--
--
Intermittent Drugs - Pediatrics
Available
As
Drug Name
Therapy
cefOXitin
pt weight < 50kg
cefOXitin
pt weight >= 50kg
cefTAZidime
pt weight < 40kg
cefTAZidime
pt weight >= 40kg
cefTRIAXone
pt weight < 40kg
cefTRIAXone
pt weight >= 40kg
cidofovir
CIPROfloxacin
pt weight < 30kg
CIPROfloxacin
pt weight >= 30kg
CLINDAmycin
pt weight < 60kg
CLINDAmycin
pt weight >= 60kg
desmopressin
desmopressin
ertapenem
pt age < = 13 years
ertapenem
pt age > = 13 years
erythromycin
fluCONazole
pt weight < 60kg
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
X
X
X
X
mg/kg
gram
25
0.25
42
2
50
--
X
X
mg/kg
25
52.5
55
X
X
gram
0.25
2
--
X
X
mg/kg
10
52.5
55
X
X
gram
0.25
2
--
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
gram/m
00:20 01:00 00:30
-0.01
0.04
L
P
S
Hard
Min
--- gram / --- mL
X
--
--
--- mg / --- mL
X
--
--
00:25
01:30
00:30 mg/mL
1 gram / 50 mL (0.02 gram / mL)
2 gram / 50 mL (0.04 gram / mL)
X
X
---
---
00:25
00:25
01:30
01:30
00:30
00:30
--- gram / --- mL
X
--
--
00:25
01:30
--- mg / --- mL
X
--
--
00:25
1 gram / 50 mL (0.02 gram / mL)
X
--
--
--- gram / --- mL
X
--
--- mg / --- mL
X
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
Concentrations
Clinical Ads.
Name
--
10
40
n/a
n/a
gram/m
00:30
L
n/a
n/a
n/a
n/a
n/a
n/a
--
10
40
01:00
00:30 mg/mL
--
10
50
00:25
01:00
00:30
n/a
n/a
n/a
--
00:25
01:00
n/a
gram/m
00:30
L
--
0.01
0.04
--
--
00:20
01:30
00:30 mg/mL
--
30
50
X
X
---
---
00:25
00:25
01:30
01:30
00:30
00:30
n/a
n/a
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:20
01:30
--
30
50
mg/mL
--
0.03
8.5
Fluid Bolus
n/a
n/a
gram/m
00:30
L
--
----
--
X
X
mg/kg
0.85
5.5
--
--- mg / --- mL
X
X
00:20
00:40
03:00
X
X
mg/kg
5
13.8
15
--- mg / --- mL
X
--
00:45
--
02:00
01:00 mg/mL
--
1
3
--
X
X
mg
200
--
200 mg / 100 mL (2 mg / mL)
400 400 mg / 200 mL (2 mg / mL)
--- mg / --- mL
X
X
X
----
00:45
00:45
00:45
----
02:00
02:00
02:00
01:00
n/a
01:00
n/a
01:00 mg/mL
n/a
n/a
--
n/a
n/a
0.5
n/a
n/a
2
--
X
X
mg/kg
5
10
12
X
--
00:15
--
01:00
00:30 mg/mL
--
3
17
--
X
X
X
X
-----
00:15
00:15
00:15
00:15
-----
01:00
01:00
01:00
01:00
00:30
n/a
00:30
n/a
00:30
n/a
00:30 mg/mL
n/a
n/a
n/a
--
n/a
n/a
n/a
3
n/a
n/a
n/a
17
--
--- mcg / --- mL
X
X
00:05
00:10
01:00
--
mcg/mL
--
0.001
0.55
--
0.5 --- mcg / --- mL
X
--
00:05
00:10
01:00
--
mcg/mL
--
0.001
0.55
--
--
5
25
--
n/a
n/a
n/a
--
--
4.5
5.5
--
1.9
--
2.1
--
--- mg / --- mL
300 mg / 50 mL (6 mg / mL)
600 mg / 50 mL (12 mg / mL)
1200
900 mg / 50 mL (18 mg / mL)
--- mg / --- mL
--
--
X
X
mg
300
900
X
X
mcg
0.01
4
X
X
mcg/kg
X
X
mg/kg
10
15
--
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
X
X
gram
0.5
1
--
1 gram / 50 mL (0.02 gram / mL)
X
--
--
00:25
01:00
00:30
X
X
mg/kg
3.5
15
--
--- mg / --- mL
X
X
--
00:20
02:00
01:00 mg/mL
X
X
mg/kg
3
12
--
--- mg / --- mL
X
--
00:55
--
03:00
WVHN - 8/12/2011 08:17
0.001 0.35
--
Page 68 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
n/a
mg/mL
Intermittent Drugs - Pediatrics
Available
As
Drug Name
Therapy
fluCONazole
pt weight >= 60kg
fomepizole
fosphenytoin
fosphenytoin
GANcyclovir
gentamicin
imipenem/cilastatin
pt weight < 40kg
imipenem/cilastatin
pt weight >= 40kg
levETIRAcetam
levoFLOXacin
pt weight < 50kg
levoFLOXacin
pt weight >= 50kg
linezolid
pt weight < 60kg
linezolid
pt weight >= 60kg
meropenem
pt weight < 50kg
meropenem
pt weight >= 50kg
methylPREDNISolone
metoCLOPramide
metoCLOPramide
metroNIDAZOLE
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Concentrations
100 mg / 50 mL (2 mg / mL)
200 mg / 100 mL (2 mg / mL)
400 mg / 200 mL (2 mg / mL)
--- mg / --- mL
P
X
X
X
X
S
---X
Hard
Min
---00:40
Duration Limits
Soft
Soft
Min
Max
00:50 02:00
00:50 02:00
01:30 03:00
00:50 03:00
Concentration Limits
Initial Conc. Hard
Soft
Soft
Value Units
Min
Min
Max
01:00
n/a
n/a
n/a
n/a
01:00
n/a
n/a
n/a
n/a
02:00
n/a
n/a
n/a
n/a
01:00 mg/mL
-1
3
Clinical Ads.
Name
X
X
mg
100
800
--
X
X
mg/kg
8
15
--
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
--
3
15
--
X
X
---
00:05
00:05
00:08
00:08
00:30
00:30
00:20
n/a
00:20 mg/mL
n/a
--
n/a
5
n/a
30
--
X
X
00:05
00:08
01:00
00:30 mg/mL
--
5
30
--
X
X
mg
25
1500
--
100 mg / 50 mL (2 mg / mL)
--- mg / --- mL
X
X
mg/kg
2
11.5
29
--- mg / --- mL
--
X
X
mg/kg
0.5
8
--
--- mg / --- mL
X
--
00:40
00:50
03:00
01:00 mg/mL
--
5
10
Filter 0.22
Micron
X
X
mg/kg
1
7.5
--
--- mg / --- mL
X
X
00:20
00:30
01:15
01:00 mg/mL
--
4
11
--
X
X
mg/kg
5
25
--
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
--
5
25
--
X
X
mg
500
1000
--
500 mg / 100 mL (5 mg / mL)
1,000 mg / 250 mL (4 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:25
00:45
00:25
01:00
01:30
01:00
00:30
n/a
01:00
n/a
00:30 mg/mL
n/a
n/a
--
n/a
n/a
5
n/a
n/a
25
--
X
X
mg
250
1500 3000 --- mg / --- mL
X
X
00:10
--
00:30
00:15 mg/mL
--
2.5
15
--
X
X
mg/kg
4
10
--
--- mg / --- mL
X
--
00:45
--
02:00
01:00 mg/mL
X
X
X
----
00:45
00:45
00:45
----
02:00
02:00
02:00
01:00
01:00
01:00
--
2.5
6
--
n/a
n/a
n/a
n/a
n/a
n/a
--
X
X
mg
250
750
--
X
X
mg/kg
4
11
--
--- mg / --- mL
X
X
00:45
--
02:00
01:00 mg/mL
--
1
3
--
X
X
mg
400
600
--
600 mg / 300 mL (2 mg / mL)
--- mg / --- mL
X
X
---
00:45
00:45
---
02:00
02:00
01:00
n/a
01:00 mg/mL
n/a
--
n/a
1
n/a
3
--
X
X
mg/kg
6.8
44
--
--- mg / --- mL
X
--
--
00:25
02:00
00:30 mg/mL
--
5
55
--
X
X
mg
500
2000
--
500 mg / 50 mL (10 mg / mL)
1,000 mg / 50 mL (20 mg / mL)
--- mg / --- mL
X
X
X
----
----
00:25
00:25
00:25
02:00
02:00
02:00
00:30
n/a
00:30
n/a
00:30 mg/mL
n/a
n/a
--
n/a
n/a
5
n/a
n/a
55
--
X
X
mg/kg
2
30
--
--- mg / --- mL
X
--
--
00:50
05:00
mg/mL
--
3
130
--
X
X
mg
5
10
--
--- mg / --- mL
X
--
--
00:10
00:30
00:15 mg/mL
--
0.1
0.2
--
X
X
mg/kg
0.07
3
--
--- mg / --- mL
X
--
--
00:03
00:30
00:15 mg/mL
--
1
6
--
X
X
mg/kg
7
16
--
--- mg / --- mL
X
X
00:30
00:50
03:00
01:00 mg/mL
--
4
6
--
WVHN - 8/12/2011 08:17
Page 69 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
n/a
n/a
n/a
n/a
n/a
n/a
250 mg / 50 mL (5 mg / mL)
500 mg / 100 mL (5 mg / mL)
750 mg / 150 mL (5 mg / mL)
Intermittent Drugs - Pediatrics
Available
As
Drug Name
Therapy
micafungin
pt weight < 40kg
micafungin
pt weight >= 40kg
nafcillin
pt weight < 40kg
nafcillin
pt weight >= 40kg
ondansetron
PHENobarbital
piperacillin/tazo
pt weight < 30kg
piperacillin/tazo
pt weight >= 30kg
ranitidine
pt weight < 50kg
ranitidine
pt weight >= 50kg
rifampin
pt weight < 60kg
rifampin
pt weight >= 60kg
SMX/TMP
ticarcillin/clav
pt weight < 60kg
ticarcillin/clav
pt weight >= 60kg
TOBRAmycin
TOBRAmycin
valproate sodium
Vanco Langlade
Vanco Medford
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
P
S
Hard
Min
X
X
mg/kg
0.85
4.5
--
--- mg / --- mL
X
X
00:40
00:50
03:00
01:00 mg/mL
--
0.4
1.7
--
X
X
mg
40
150
--
--- mg / --- mL
X
X
00:40
00:50
03:00
01:00 mg/mL
--
0.4
1.7
--
X
X
mg/kg
20
52
--
--- mg / --- mL
X
--
--
00:30
01:30
01:00 mg/mL
--
10
40
--
1 gram / 50 mL (0.02 gram / mL)
2 gram / 100 mL (0.02 gram / mL)
X
X
---
---
00:30
00:30
02:00
02:00
01:00
01:00
n/a
n/a
n/a
n/a
n/a
n/a
--- gram / --- mL
X
--
--
00:30
02:00
n/a
n/a
gram/m
01:00
L
--
0.01
0.04
00:30 mg/mL
--
0.001
4.2
--
--
60
135
High Risk
--
X
X
gram
0.2
2
--
Concentrations
X
X
mg/kg
0.1
0.5
--
--- mg / --- mL
X
X
--
00:10
01:00
X
X
mg/kg
0.5
7.5
--
--- mg / --- mL
X
X
00:05
00:08
02:00
--
X
X
gram/kg
--
--- gram / --- mL
X
--
--
00:25
01:00
00:30
3.37 gram / 50 mL (0.067 gram / mL)
X
--
--
00:25
01:00
--- gram / --- mL
X
--
--
00:25
01:00
--- mg / --- mL
X
X
00:03
00:10
01:00
150 --- mg / --- mL
X
X
00:03
00:10
01:00
--
0.03 0.115
mg/mL
--
gram/m
L
00:30
n/a
gram/m
00:30
L
--
0.02
0.085
n/a
n/a
n/a
--
0.02
0.085
00:30 mg/mL
--
2
3
--
mg/mL
--
2
3
--
X
X
gram
2
3.4
--
X
X
mg/kg
0.4
2.5
--
X
X
mg
25
50
X
X
mg/kg
4.3
23
--
--- mg / --- mL
X
X
00:20
00:25
03:00
--
mg/mL
--
2
7
--
X
X
mg
300
600
--
--- mg / --- mL
X
X
00:20
00:25
03:00
--
mg/mL
--
2
7
--
X
X
mg/kg
1.5
6
--
--- mg / --- mL
X
--
00:40
--
02:00
01:00 mg/mL
--
0.04
1
--
X
X
mg/kg
30
65
--
--- mg / --- mL
X
X
00:08
00:20
02:00
00:30 mg/mL
--
20
105
--
3.1 gram / 100 mL (0.031 gram / mL)
X
--
--
00:20
02:00
00:30
n/a
n/a
X
gram
1.5
3.1
--
--- gram / --- mL
X
--
--
00:20
01:00
n/a
gram/m
00:30
L
n/a
X
--
0.02
0.105
X
X
mg
60
600
--
--- mg / --- mL
X
--
--
00:25
01:00
00:30 mg/mL
--
0.5
10
--
X
X
mg/kg
0.8
4.6
7.5 --- mg / --- mL
X
X
00:20
00:25
01:15
mg/mL
--
0.5
10
--
X
X
mg/kg
2.5
20
25
--- mg / --- mL
X
--
00:40
00:50
02:00
01:00 mg/mL
--
5
25
--
X
X
mg
100
2000
--
--- mg / --- mL
X
--
--
00:30
03:30
--
mg/mL
--
1
6
--
X
X
mg
100
2000
--
--- mg / --- mL
X
--
--
00:30
03:30
--
mg/mL
--
1
6
--
WVHN - 8/12/2011 08:17
Page 70 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
--
--
--
Intermittent Drugs - Pediatrics
Available
As
Total Dose Limits
Dosing Soft Soft Hard
Pri. Sec. Units
Min Max Max
Drug Name
Therapy
Vanco Wausau
VANCOmycin
VORIconazole
zidovudine
Module
Duration Limits
Concentration Limits
Soft
Soft Initial Conc. Hard
Soft
Soft
Min
Max Value Units
Min
Min
Max
Clinical Ads.
Name
P
S
Hard
Min
X
X
mg
210
2000
--
--- mg / --- mL
X
--
--
00:30
03:30
--
mg/mL
--
0.5
5
--
X
X
mg/kg
5
25
--
--- mg / --- mL
X
--
--
00:30
03:30
--
mg/mL
--
0.2
5
--
X
X
mg/kg
2.6
6.9
--
--- mg / --- mL
X
X
--
00:50
02:10
--
mg/mL
--
0.4
5.5
--
X
X
mg/kg
0.8
2.3
--
--- mg / --- mL
X
--
--
00:25
03:00
00:30 mg/mL
--
2
4
--
Concentrations
2.6.6 Fluids
Fluid Name
Therapy
..Maintenance IVF
.IVF + KCL 10 mEq/L
.IVF + KCL 20 mEq/L
.IVF + KCL 30 mEq/L
.IVF + KCL 40 mEq/L
Blood (Cryoprecipit)
Blood (FFP)
Blood (platelets)
Blood (PRBCs)
Blood (whole)
Dextrose 10%
Lipids 20%
TPN
TPN - Cyclic
Supports
Secondary
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
No
Yes
No
No
No
Fluids - Pediatrics
Module
Rate Limits (mL/h)
P
S
Soft Soft Hard
Min
Max Max
X
X
0.1
500
-X
X
0.1
200
-X
X
0.1
200
-X
X
0.1
200
350
X
X
0.1
200
275
X
X
10
300
-X
X
0.1
50
-X
X
5
300
-X
X
0.1
50
-X
-5
200
-X
X
1
50
-X
X
0.1
42
-X
-15
100
150
X
-15
250
300
Clinical Ads. Name
-------Dedicated IV Line
-Dedicated IV Line
---Central Line Only
2.6.7 PCA Drugs
No drugs exist in this section.
WVHN - 8/12/2011 08:17
Page 71 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
3. Configuration Settings
Settings
Alarm Audio Profile
Audio Volume
Anesthesia Mode
Battery Meter Display
Color Display
Key Click Audio
Limit Checking
Max Patient BSA (m2)
MaxPatient Weight (kg)
Patient ID Entry
Pending IV Orders
Preventive
Maintenance Reminder
Tamper Resistant
Authorized User
Mode
WVHN - 8/12/2011 08:17
Pediatrics
Oncology
NICU
Med Surg
L&D
Critical Care
3.1 PC Unit
Profile 1 Profile 1 Profile 1 Profile 1 Profile 1 Profile 1
5
5
5
3
5
5
Enabled Enabled Enabled Enabled Enabled Enabled
Enabled Enabled Enabled Enabled Enabled Enabled
Enabled Enabled Enabled Enabled Enabled Enabled
Enabled Enabled Enabled Enabled Enabled Enabled
Always
Always
Always
Always
Always
Always
3
3
3
3
3
3
500
500
500
9
500
58
Enabled Enabled Enabled Enabled Enabled Enabled
Disabled Disabled Disabled Disabled Disabled Disabled
Disabled Disabled Disabled Disabled Disabled Disabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Disabled Disabled Disabled Disabled Disabled Disabled
Page 72 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
NICU
Oncology
Pediatrics
Settings
Accumulated Air-InEnabled Enabled
Line
Air-In-Line (microliters)
250
250
Auto-Restart Attempts
3
3
KVO Rate Adjust
5
5
(mL/h)
Max Occlusion
525
525
Pressure (mmHg)
Max Occlusion
Pressure Initial Value
525
525
(mmHg)
Maximum Rate (mL/h)
999
999
Maximum VTBI (mL)
3100
3100
Pressure Mode Lock
Unlocked Unlocked
Status
Pressure Mode
Pump
Pump
Selection
Secondary Infusion
Enabled Enabled
SEC-PRI Audio Alert
Disabled Disabled
Med Surg
L&D
Critical Care
3.2 Pump Module
Enabled
Enabled
Enabled
Enabled
250
3
50
0
75
0
75
3
5
1
1
5
525
525
425
525
525
525
425
525
999
3100
200
499
999
3100
999
2050
Unlocked Unlocked Unlocked Unlocked
Pump
Pump
Pump
Pump
Enabled Disabled Enabled Enabled
Disabled
n/a
Disabled Disabled
WVHN - 8/12/2011 08:17
L&D
Med Surg
NICU
Oncology
Pediatrics
Settings
All Mode
Auto Occlusion
Pressure
Critical Care
3.3 Syringe Module
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Page 73 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Critical Care
L&D
Med Surg
NICU
Oncology
Pediatrics
Settings
Back-Off After
Occlusion
Fast-Start
KVO Option
KVO Rate Adjust
(mL/h)
KVO Volume Adjust
(%)
Near End Of Infusion
Nea End Of Infusion
Alert Time (minutes)
Occlusion Pressure
Limit With Disc (mmHg)
Occlusion Pressure
Limit No Disc
Priming
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled Enabled Enabled Enabled Enabled Enabled
Disabled Disabled Disabled Disabled Disabled Disabled
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Disabled Disabled Disabled Disabled Disabled Disabled
n/a
n/a
n/a
n/a
n/a
n/a
1000
1000
1000
1000
1000
1000
High
High
High
High
High
High
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Settings
Delay Start Options
Delay Start Callback
Pediatrics
Oncology
NICU
Med Surg
L&D
Critical Care
3.4 Shared Infusion Settings (Pump and Syringe)
Enabled Enabled Enabled Enabled Enabled Enabled
BeforeAn BeforeAn BeforeAn BeforeAn BeforeAn BeforeAn
dAfter
dAfter
dAfter
dAfter
dAfter
dAfter
Enabled Enabled Enabled Enabled Enabled Enabled
Drug Calculation
Drug Calculation Bolus
Enabled Enabled Enabled Enabled Enabled Enabled
Dose
Multidose
Disabled Disabled Disabled Disabled Disabled Disabled
Multidose Callback
n/a
n/a
n/a
n/a
n/a
n/a
Pressure Dynamic
Enabled Enabled Enabled Enabled Enabled Enabled
Display
WVHN - 8/12/2011 08:17
Page 74 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Critical Care
L&D
Med Surg
NICU
Oncology
Pediatrics
Settings
Volume Duration
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
WVHN - 8/12/2011 08:17
L&D
Med Surg
NICU
Oncology
Pediatrics
Settings
Bolus Delivery Rate
(mL/h)
Dose Request Cord
(Profile)
Max Dose Limit
Max Dose Limit Time
Window (h)
Module Location
Enforcement
Near End of Infusion
Near End 0f Infusion
Alert Time (%)
Pressure Limit
Priming
Security Access Level
Security Code
Critical Care
3.5 PCA Module
150
150
150
150
150
150
2
2
2
2
2
2
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
4
4
4
1
4
1
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
Enabled
5
5
5
5
5
5
High
Enabled
1
n/a
High
Enabled
1
n/a
High
Enabled
1
n/a
High
Enabled
1
n/a
High
Enabled
1
n/a
High
Enabled
1
n/a
Page 75 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
L&D
Med Surg
NICU
Oncology
Pediatrics
Settings
Maximum Rate (mL/h)
Critical Care
3.6 Shared Infusion Settings (PCA and Syringe)
999
999
999
200
999
999
WVHN - 8/12/2011 08:17
L&D
Med Surg
NICU
Oncology
Pediatrics
Settings
SpO2 Module Type
Pulse Beep Volume
SatSeconds Limits:
Sat. Averaging Time
(Seconds)
Alarm Limit Type
%SpO2 High
%SpO2 Low
Pulse Rate High
(beats/min)
Pulse Rate Low
(beats/min)
Critical Care
3.7 SpO2 Module
Both
1
25
Both
1
25
Both
1
25
Both
1
25
Both
1
25
Both
1
25
8
8
8
8
8
8
Adult
n/a
90
Adult
n/a
90
Adult
n/a
90
Adult
n/a
90
Adult
n/a
90
Adult
n/a
90
120
120
120
120
120
120
50
50
50
50
50
50
Page 76 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
L&D
Med Surg
NICU
Oncology
Pediatrics
Settings
Alarm Limit Type
EtCO2 High (mmHg)
EtCO2 Low (mmHg)
Respiratory Rate High
(bpm)
Respiratory Rate Low
(bpm)
No Breath Alarm
(Seconds)
FiCO2 High
Waveform Time Scale
(Seconds)
Critical Care
3.8 EtCO2 Module
Adult
60
10
Adult
60
10
Adult
60
10
Adult
60
10
Adult
60
10
Adult
60
10
35
35
35
35
35
35
6
6
6
6
6
6
30
30
30
30
30
30
8
8
8
8
8
8
5
5
5
10
5
10
3.9 PCA Pause Protocol
Oncology
Med Surg
L&D
Critical Care
3.9.1 PCA Pause Protocol Settings
Settings
PCA Pause Protocol
Enabled Enabled Enabled Enabled
Enabled
Available for
Etco2
Etco2
Etco2
Etco2
Monitoring Module
Disabled Disabled Disabled Disabled
Attach Enforcement
PCA Pause Protocol: PCA Infusion has paused due to a decline
in respiratory status. Check Patient!
WVHN - 8/12/2011 08:17
Page 77 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
L&D
Med Surg
Oncology
Settings
%SpO2 Low Limit
Initial Value (%)
Critical Care
3.9.2 PCA Pause Protocol (SpO2) Settings
---
---
---
---
WVHN - 8/12/2011 08:17
L&D
Med Surg
Oncology
Settings
Resp. Rate Lower Limit
(bpm)
Resp. Rate Initial Value
(bpm)
Critical Care
3.9.3 PCA Pause Protocol (EtCO2) Settings
4
4
4
4
5
5
5
5
Page 78 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
4. Channel Labels
Channel labels are not used
WVHN - 8/12/2011 08:17
Page 79 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Appendices
Appendix A Syringe Favorites List
Syringe Favorites
SyringeType
BD Plastipak 1 mL
BD Plastipak 3 mL
BD Plastipak 5 mL
BD Plastipak 10 mL
BD Plastipak 20 mL
BD Plastipak 30 mL
BD Plastipak 50 and 60 mL
Monoject 3 mL
Monoject 6 mL
Monoject 12 mL
Monoject 20 mL
Monoject 35 mL
Monoject 60 mL
Terumo 3 mL
Terumo 5 mL
Terumo 10 mL
Terumo 20 mL
Terumo 30 mL
Terumo 50 and 60 mL
AstraZeneca 50 mL
IVAC 50 mL
Included
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Appendix B PCA Syringe Favorites List
PCA Syringe Favorites
Syringe Type
Included
BD Plastipak 20 mL
X
BD Plastipak 30 mL
X
BD Plastipak 50 and 60 mL
X
Monoject 20 mL
X
Monoject 35 mL
X
Monoject 60 mL
X
Terumo 20 mL
X
Terumo 30 mL
X
Terumo 50 and 60 mL
X
IMS 30 mL Prefill
X
WVHN - 8/12/2011 08:17
Page 80 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)
Appendix C Clinical Advisories List
Advisory Name
12 Hour Tubing
1unit=1million
2nd RN to verify
48 Hour Tubing
Calcium Precipitate
Central Line Only
Central preferred
Code only drugs
CrCl < 50 mL/min
CrCl > 50 mL/min
Dedicated IV Line
DEHP
Dextrose only
DHEP and Lactate
Filter 0.22 Micron
Filter and light
Fluid Bolus
gram/kg = mg/kg/hour
Heparin
High Risk
Hypersensitivity
Neuromuscular BA
Non-PVC
NOTE CONCENTRATION
Protect From Light
Stress Test
Vesicant
WVHN - 8/12/2011 08:17
Clinical Advisories
Clinical Advisory Text
Tubing must be changed every 12 hours
1 unit = 1 million units
2 RNs to verify and document concentration and programming prior to infusion.
Change tubing every 48 hours.
Do not infuse Calcium and Phosphate though the same line.
Run through a CENTRAL line only.
Central line administration preferred. When administration via peripheral site change site every 12 hours. Do not mix with other
agents in IV line.
This selection is reserved for use during Code Pink, ACLS events. DO NOT USE for routine infusions!
Maximum dose in patients with CrCl less than 50 mL/min is 1 mcg/kg/min up to 7.5 mg/hour.
Dosing for patients with CrCl greater than 50 mL/min
Do not infuse any other drugs through this line.
This medication must be infused using DEHP FREE tubing.
Flush with D5W only: NO SALINE
This medication must be infused via DHEP free tubing and with LACTATED Ringers only
Infusion requires the use of an in-line 0.22 micron filter
Inline 0.22 micron filter required and protection from light.
Administer a fluid bolus prior to starting the cidofovir infusion.
Please note: 0.1242 grams/kg is infused over 23 hours to be equal to 5.4 mg/kg/hour infused over 23 hours for spinal cord injuries.
Monitor PTT. Do not administer other drugs through same IV line.
This is a HIGH RISK medication. 2nd RN to verify prior to initiating therapy.
Risk of hypersensitivity. Check vital signs frequently during infusion.
*Train of Four Required* Mechanical Ventilation and concurrent Sedation is mandatory.
This medication must be infused using Non-PVC tubing.
Program 2 units/mL heparin as 1 unit/mL in order to bolus during EP procedures. 1 unit per hour = 1 mL per hour..
Protect this drug from light.
For STRESS TEST only.
Drug is a vesicant. Check blood return.
Page 81 of 81
WVHN 8-16-2011, 015d79e05-A
Reviewed and Approved by __________________________________Date___________(Approval Only)